Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


Articles published in Psychiatry Res

Retrieve available abstracts of 561 articles:
HTML format
Text format



Single Articles


    May 2018
  1. HU TM, Ping LY, Hsu SH, Tsai HY, et al
    Mutation analysis of the WNT7A gene in patients with schizophrenia.
    Psychiatry Res. 2018;265:246-248.
    PubMed     Text format     Abstract available


  2. KANNO-NOZAKI K, Miura I, Kaneko H, Horikoshi S, et al
    Influences of the T102C polymorphism in the 5-HT2A receptor gene on the five-factor model of Positive and Negative Syndrome Scale and treatment response to aripiprazole in patients with acute schizophrenia.
    Psychiatry Res. 2018;265:244-245.
    PubMed     Text format    


  3. LABAD J, Armario A, Nadal R, Sole M, et al
    Clinical correlates of hypothalamic-pituitary-adrenal axis measures in individuals at risk for psychosis and with first-episode psychosis.
    Psychiatry Res. 2018;265:284-291.
    PubMed     Text format     Abstract available


  4. GROVE TB, Yao B, Mueller SA, McLaughlin M, et al
    A Bayesian model comparison approach to test the specificity of visual integration impairment in schizophrenia or psychosis.
    Psychiatry Res. 2018;265:271-278.
    PubMed     Text format     Abstract available


  5. CHOW TJ, Tee SF, Loh SY, Yong HS, et al
    Variants in ZNF804A and DTNBP1 assessed for cognitive impairment in schizophrenia using a multiplex family-based approach.
    Psychiatry Res. 2018 May 7. pii: S0165-1781(18)30118.
    PubMed     Text format    


  6. ZHU B, Chen C, Loftus EF, Dong Q, et al
    Intellectual factors in false memories of patients with schizophrenia.
    Psychiatry Res. 2018;265:256-262.
    PubMed     Text format     Abstract available


    April 2018
  7. DAS S, Punnoose VP, Doval N, Nair VY, et al
    Spirituality, religiousness and coping in patients with schizophrenia: A cross sectional study in a tertiary care hospital.
    Psychiatry Res. 2018;265:238-243.
    PubMed     Text format     Abstract available


  8. KURTZ MM, Gopal S, John S, Thara R, et al
    Cognition, social cognition and functional disability in early-stage schizophrenia: A study from southern India.
    Psychiatry Res. 2018;265:231-237.
    PubMed     Text format     Abstract available


  9. ZHOU W, Shi Y, Li F, Wu X, et al
    Study of the association between Schizophrenia and microduplication at the 16p11.2 locus in the Han Chinese population.
    Psychiatry Res. 2018;265:198-199.
    PubMed     Text format     Abstract available


  10. DE JONG S, van Donkersgoed R, Renard S, Carter S, et al
    Social-cognitive risk factors for violence in psychosis: A discriminant function analysis.
    Psychiatry Res. 2018;265:93-99.
    PubMed     Text format     Abstract available


  11. BONFILS KA, Minor KS, Leonhardt BL, Lysaker PH, et al
    Metacognitive self-reflectivity moderates the relationship between distress tolerance and empathy in schizophrenia.
    Psychiatry Res. 2018;265:1-6.
    PubMed     Text format     Abstract available


  12. MOHAMMADI A, Rashidi E, Amooeian VG
    Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia.
    Psychiatry Res. 2018;265:25-38.
    PubMed     Text format     Abstract available


  13. STRUGSTAD B, Lau B, Glenne Oie M
    Associations between cognition and internalizing problems in young adults with early-onset schizophrenia: A 13-year follow-up study.
    Psychiatry Res. 2018;265:161-166.
    PubMed     Text format     Abstract available


  14. YE F, Zhan Q, Xiao W, Tang X, et al
    Altered serum levels of vascular endothelial growth factor in first-episode drug-naive and chronic medicated schizophrenia.
    Psychiatry Res. 2018;264:361-365.
    PubMed     Text format     Abstract available


  15. ZHAO S, Xia H, Mu J, Wang L, et al
    10-year CVD risk in Han Chinese mainland patients with schizophrenia.
    Psychiatry Res. 2018;264:322-326.
    PubMed     Text format     Abstract available


  16. MA J, Shang S, Wang J, Zhang T, et al
    Identification of miR-22-3p, miR-92a-3p, and miR-137 in peripheral blood as biomarker for schizophrenia.
    Psychiatry Res. 2018;265:70-76.
    PubMed     Text format     Abstract available


  17. ANDERSEN EH, Lewis GF, Belger A
    Aberrant parasympathetic reactivity to acute psychosocial stress in male patients with schizophrenia spectrum disorders.
    Psychiatry Res. 2018;265:39-47.
    PubMed     Text format     Abstract available


  18. XU YM, Li F, Liu XB, Zhong BL, et al
    Depressive symptoms in Chinese male inpatients with schizophrenia: Prevalence and clinical correlates.
    Psychiatry Res. 2018;264:380-384.
    PubMed     Text format     Abstract available


  19. VOCE A, McKetin R, Burns R, Castle D, et al
    The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses.
    Psychiatry Res. 2018;265:19-24.
    PubMed     Text format     Abstract available


  20. HICKLING LM, Kouvaras S, Nterian Z, Perez-Iglesias R, et al
    Non-adherence to antipsychotic medication in first-episode psychosis patients.
    Psychiatry Res. 2018;264:151-154.
    PubMed     Text format     Abstract available


    March 2018
  21. KANG M, Bang M, Lee SY, Lee E, et al
    Coping styles in individuals at ultra-high risk for psychosis: Associations with cognitive appraisals.
    Psychiatry Res. 2018;264:162-168.
    PubMed     Text format     Abstract available


  22. GUO W, Zhang F, Liu F, Chen J, et al
    Cerebellar abnormalities in first-episode, drug-naive schizophrenia at rest.
    Psychiatry Res. 2018 Mar 29. pii: S0925-4927(17)30308.
    PubMed     Text format     Abstract available


  23. MATSUMOTO J, Nagaoka A, Kunii Y, Miura I, et al
    Effects of the -141C insertion/deletion polymorphism in the dopamine D2 receptor gene on the dopamine system in the striatum in patients with schizophrenia.
    Psychiatry Res. 2018;264:116-118.
    PubMed     Text format     Abstract available


  24. ABUSH H, Ghose S, Van Enkevort EA, Clementz BA, et al
    Associations between adolescent cannabis use and brain structure in psychosis.
    Psychiatry Res. 2018 Mar 28. pii: S0925-4927(17)30314.
    PubMed     Text format     Abstract available


  25. THONSE U, Behere RV, Praharaj SK, Sharma PSVN, et al
    Facial emotion recognition, socio-occupational functioning and expressed emotions in schizophrenia versus bipolar disorder.
    Psychiatry Res. 2018;264:354-360.
    PubMed     Text format     Abstract available


  26. AYDIN O, Lysaker PH, Balikci K, Unal-Aydin P, et al
    Associations of oxytocin and vasopressin plasma levels with neurocognitive, social cognitive and meta cognitive function in schizophrenia.
    Psychiatry Res. 2018 Mar 23. pii: S0165-1781(17)31776.
    PubMed     Text format     Abstract available


  27. LIN CH, Lin SC, Huang YH, Wang FC, et al
    Early prediction of olanzapine-induced weight gain for schizophrenia patients.
    Psychiatry Res. 2018;263:207-211.
    PubMed     Text format     Abstract available


  28. KIM DD, Barr AM, Thornton AE, Honer WG, et al
    Statin add-on therapy for schizophrenia: Is the effect the same for clozapine?
    Psychiatry Res. 2018 Mar 22. pii: S0165-1781(18)30090.
    PubMed     Text format    


  29. VAZQUEZ MOREJON AJ, Vazquez-Morejon R, Bellido Zanin G
    Behavior Problems Inventory (BPI): Psychometric characteristics of an instrument for routine assessment of persons with psychoses and related disorders.
    Psychiatry Res. 2018 Mar 22. pii: S0165-1781(17)31662.
    PubMed     Text format     Abstract available


  30. KOTHER U, Lincoln TM, Moritz S
    Emotion perception and overconfidence in errors under stress in psychosis.
    Psychiatry Res. 2018 Mar 21. pii: S0165-1781(17)31081.
    PubMed     Text format     Abstract available


  31. WARD HB, Szabo ST, Rakesh G
    Maintenance ECT in schizophrenia: A systematic review.
    Psychiatry Res. 2018;264:131-142.
    PubMed     Text format     Abstract available


  32. DEGNAN A, Berry K, James S, Edge D, et al
    Development, validation and cultural-adaptation of the knowledge about psychosis questionnaire for African-Caribbean people in the UK.
    Psychiatry Res. 2018;263:199-206.
    PubMed     Text format     Abstract available


  33. LINDGREN M, Torniainen-Holm M, Heiskanen I, Voutilainen G, et al
    Theory of mind in a first-episode psychosis population using the Hinting Task.
    Psychiatry Res. 2018;263:185-192.
    PubMed     Text format     Abstract available


  34. XIU MH, Wang D, Chen S, Du XD, et al
    Interleukin-3, symptoms and cognitive deficits in first-episode drug-naive and chronic medicated schizophrenia.
    Psychiatry Res. 2018;263:147-153.
    PubMed     Text format     Abstract available


  35. DE MOURA AM, Pinaya WHL, Gadelha A, Zugman A, et al
    Investigating brain structural patterns in first episode psychosis and schizophrenia using MRI and a machine learning approach.
    Psychiatry Res. 2018 Mar 6. pii: S0925-4927(17)30133.
    PubMed     Text format     Abstract available


  36. THOMAS EC, Murakami-Brundage J, Bertolami N, Beck AT, et al
    Beck Self-Esteem Scale-Short Form: Development and psychometric evaluation of a scale for the assessment of self-concept in schizophrenia.
    Psychiatry Res. 2018;263:173-180.
    PubMed     Text format     Abstract available


  37. JOE P, Ahmad M, Riley G, Weissman J, et al
    A pilot study assessing retinal pathology in psychosis using optical coherence tomography: Choroidal and macular thickness.
    Psychiatry Res. 2018;263:158-161.
    PubMed     Text format     Abstract available


  38. KRUKOW P, Jonak K, Karakula-Juchnowicz H, Podkowinski A, et al
    Disturbed functional connectivity within the left prefrontal cortex and sensorimotor areas predicts impaired cognitive speed in patients with first-episode schizophrenia.
    Psychiatry Res. 2018 Mar 4. pii: S0925-4927(18)30018.
    PubMed     Text format     Abstract available


    February 2018
  39. AIKAWA S, Kobayashi H, Nemoto T, Matsuo S, et al
    Social anxiety and risk factors in patients with schizophrenia: Relationship with duration of untreated psychosis.
    Psychiatry Res. 2018;263:94-100.
    PubMed     Text format     Abstract available


  40. BRIEND F, Nathou C, Kauffmann F, Delcroix N, et al
    Theta burst stimulation on social cognition and N-Acetyl aspartate in two patients with schizophrenia.
    Psychiatry Res. 2018 Feb 18. pii: S0925-4927(17)30344.
    PubMed     Text format    


  41. HANSBAUER M, Wobrock T, Kunze B, Langguth B, et al
    Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis.
    Psychiatry Res. 2018;263:22-29.
    PubMed     Text format     Abstract available


  42. PAUSELLI L, Halpern B, Cleary SD, Ku B, et al
    Computational linguistic analysis applied to a semantic fluency task to measure derailment and tangentiality in schizophrenia.
    Psychiatry Res. 2018;263:74-79.
    PubMed     Text format     Abstract available


  43. MAN L, Lv X, Du XD, Yin G, et al
    Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
    Psychiatry Res. 2018;263:1-6.
    PubMed     Text format     Abstract available


  44. SUM MY, Tay KH, Sengupta S, Sim K, et al
    Neurocognitive functioning and quality of life in patients with and without deficit syndrome of schizophrenia.
    Psychiatry Res. 2018;263:54-60.
    PubMed     Text format     Abstract available


  45. BUSTAN Y, Drapisz A, Ben Dor DH, Avrahami M, et al
    Elevated neutrophil to lymphocyte ratio in non-affective psychotic adolescent inpatients: Evidence for early association between inflammation and psychosis.
    Psychiatry Res. 2018;262:149-153.
    PubMed     Text format     Abstract available


  46. CANTISANI A, Stegmayer K, Federspiel A, Bohlhalter S, et al
    Blood perfusion in left inferior and middle frontal gyrus predicts communication skills in schizophrenia.
    Psychiatry Res. 2018 Feb 10. pii: S0925-4927(17)30229.
    PubMed     Text format     Abstract available


  47. CLELLAND JD, Read LL, Smeed J, Clelland CL, et al
    Regulation of cortical and peripheral GCH1 expression and biopterin levels in schizophrenia-spectrum disorders.
    Psychiatry Res. 2018;262:229-236.
    PubMed     Text format     Abstract available


  48. MCGREGOR N, Thompson N, O'Connell KS, Emsley R, et al
    Modification of the association between antipsychotic treatment response and childhood adversity by MMP9 gene variants in a first-episode schizophrenia cohort.
    Psychiatry Res. 2018;262:141-148.
    PubMed     Text format     Abstract available


  49. ZHANG T, Xu L, Cui H, Tang Y, et al
    Changes in correlation characteristics of time consumption and mind-reading performance in pre-onset and post-onset psychosis.
    Psychiatry Res. 2018;262:168-174.
    PubMed     Text format     Abstract available


  50. JOHANNESEN JK, Fiszdon JM, Weinstein A, Ciosek D, et al
    The Social Attribution Task - Multiple Choice (SAT-MC): Psychometric comparison with social cognitive measures for schizophrenia research.
    Psychiatry Res. 2018;262:154-161.
    PubMed     Text format     Abstract available


  51. SHEN H, Li R, Yan R, Zhou X, et al
    Adjunctive therapy with statins in schizophrenia patients: A meta-analysis and implications.
    Psychiatry Res. 2018;262:84-93.
    PubMed     Text format     Abstract available


  52. GHAJAR A, Khoaie-Ardakani MR, Shahmoradi Z, Alavi AR, et al
    L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial.
    Psychiatry Res. 2018;262:94-101.
    PubMed     Text format     Abstract available


    January 2018
  53. PLITMAN E, Chavez S, Nakajima S, Iwata Y, et al
    Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.
    Psychiatry Res. 2018;273:16-24.
    PubMed     Text format     Abstract available


  54. LI X, Tian Q, Bo Q, Zhang G, et al
    Impact of childhood trauma on sensorimotor gating in Chinese patients with chronic schizophrenia.
    Psychiatry Res. 2018;263:69-73.
    PubMed     Text format     Abstract available


  55. ZHANG X, Gao J, Zhu F, Wang W, et al
    Reduced white matter connectivity associated with auditory verbal hallucinations in first-episode and chronic schizophrenia: A diffusion tensor imaging study.
    Psychiatry Res. 2018 Jan 25. pii: S0925-4927(17)30315.
    PubMed     Text format     Abstract available


  56. KIM DD, Lang DJ, Procyshyn RM, Woodward ML, et al
    Reduced cardiovascular fitness associated with exposure to clozapine in individuals with chronic schizophrenia.
    Psychiatry Res. 2018;262:28-33.
    PubMed     Text format     Abstract available


  57. SEVILLA-LLEWELLYN-JONES J, Camino G, Russo DA, Painter M, et al
    Clinically significant personality traits in individuals at high risk of developing psychosis.
    Psychiatry Res. 2018;261:498-503.
    PubMed     Text format     Abstract available


  58. MORKVED N, Winje D, Dovran A, Arefjord K, et al
    Childhood trauma in schizophrenia spectrum disorders as compared to substance abuse disorders.
    Psychiatry Res. 2018;261:481-487.
    PubMed     Text format     Abstract available


  59. FELDHAUS T, Falke S, von Gruchalla L, Maisch B, et al
    The impact of self-stigmatization on medication attitude in schizophrenia patients.
    Psychiatry Res. 2018;261:391-399.
    PubMed     Text format     Abstract available


  60. HO KKY, Lui SSY, Wang Y, Yeung HKH, et al
    Theory of mind performances in first-episode schizophrenia patients: An 18-month follow-up study.
    Psychiatry Res. 2018;261:357-360.
    PubMed     Text format     Abstract available


  61. SOYATA AZ, Akisik S, Inhanli D, Noyan H, et al
    Relationship of obsessive-compulsive symptoms to clinical variables and cognitive functions in individuals at ultra high risk for psychosis.
    Psychiatry Res. 2018;261:332-337.
    PubMed     Text format     Abstract available


  62. SURI G, Lavaysse LM, Young G, Moodie C, et al
    An investigation into the drivers of avolition in schizophrenia.
    Psychiatry Res. 2018;261:225-231.
    PubMed     Text format     Abstract available


  63. DENG H, Mohite S, Suchting R, Nielsen DA, et al
    Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders.
    Psychiatry Res. 2018;261:248-252.
    PubMed     Text format     Abstract available


  64. KOIKE S, Yamaguchi S, Ojio Y, Ando S, et al
    Social distance toward people with schizophrenia is associated with favorable understanding and negative stereotype.
    Psychiatry Res. 2018;261:264-268.
    PubMed     Text format     Abstract available


    December 2017
  65. NIMGAONKAR VL, Dickerson F, Pouget JG, Chowdari K, et al
    Joint evaluation of serum C-Reactive Protein levels and polygenic risk scores as risk factors for schizophrenia.
    Psychiatry Res. 2017;261:148-153.
    PubMed     Text format     Abstract available


  66. WANG L, Jin S, He K, Chen X, et al
    Increased delayed reward during intertemporal decision-making in schizophrenic patients and their unaffected siblings.
    Psychiatry Res. 2017;262:246-253.
    PubMed     Text format     Abstract available


  67. UNAL K, Yuksel RN, Turhan T, Sezer S, et al
    The association of serum nesfatin-1 and ghrelin levels with metabolic syndrome in patients with schizophrenia.
    Psychiatry Res. 2017;261:45-49.
    PubMed     Text format     Abstract available


  68. MEZQUIDA G, Cabrera B, Martinez-Aran A, Vieta E, et al
    Detection of early psychotic symptoms: Validation of the Spanish version of the "Symptom Onset in Schizophrenia (SOS) inventory".
    Psychiatry Res. 2017;261:68-72.
    PubMed     Text format     Abstract available


  69. WON GH, Kim JW, Choi TY, Lee YS, et al
    Theta-phase gamma-amplitude coupling as a neurophysiological marker in neuroleptic-naive schizophrenia.
    Psychiatry Res. 2017;260:406-411.
    PubMed     Text format     Abstract available


  70. WOOD L, Byrne R, Enache G, Morrison AP, et al
    A brief cognitive therapy intervention for internalised stigma in acute inpatients who experience psychosis: A feasibility randomised controlled trial.
    Psychiatry Res. 2017;262:303-310.
    PubMed     Text format     Abstract available


  71. BEHDANI F, Roudbaraki SN, Saberi-Karimian M, Tayefi M, et al
    Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate.
    Psychiatry Res. 2017;261:243-247.
    PubMed     Text format     Abstract available


  72. VAN NIEROP M, Lecei A, Myin-Germeys I, Collip D, et al
    Stress reactivity links childhood trauma exposure to an admixture of depressive, anxiety, and psychosis symptoms.
    Psychiatry Res. 2017;260:451-457.
    PubMed     Text format     Abstract available


  73. PENNER J, Osuch EA, Schaefer B, Theberge J, et al
    Higher order thalamic nuclei resting network connectivity in early schizophrenia and major depressive disorder.
    Psychiatry Res. 2017;272:7-16.
    PubMed     Text format     Abstract available


  74. MOODY G, Miller BJ
    Total and differential white blood cell counts and hemodynamic parameters in first-episode psychosis.
    Psychiatry Res. 2017;260:307-312.
    PubMed     Text format     Abstract available


  75. LEENDERTSE P, Myin-Germeys I, Lataster T, Simons CJP, et al
    Subjective quality of life in psychosis: Evidence for an association with real world functioning?
    Psychiatry Res. 2017;261:116-123.
    PubMed     Text format     Abstract available


  76. OLIVEIRA IAF, Guimaraes TM, Souza RM, Dos Santos AC, et al
    Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling study.
    Psychiatry Res. 2017 Dec 5. pii: S0925-4927(17)30214.
    PubMed     Text format     Abstract available


  77. MOHN C, Torgalsboen AK
    Details of attention and learning change in first-episode schizophrenia.
    Psychiatry Res. 2017;260:324-330.
    PubMed     Text format     Abstract available


  78. LIN YC, Lai CL, Chan HY
    The association between rehabilitation programs and metabolic syndrome in chronic inpatients with schizophrenia.
    Psychiatry Res. 2017;260:227-232.
    PubMed     Text format     Abstract available


    November 2017
  79. ZHOU SS, Zhou Y
    Is the association between season of birth and schizophrenia due to neonatal cold exposure-induced permanent defects in skin functions?
    Psychiatry Res. 2017 Nov 28. pii: S0165-1781(17)30390.
    PubMed     Text format    


  80. TANG SF, Chen IH, Chiang HY, Wu CT, et al
    A comparison between the original and Tablet-based Symbol Digit Modalities Test in patients with schizophrenia: Test-retest agreement, random measurement error, practice effect, and ecological validity.
    Psychiatry Res. 2017;260:199-206.
    PubMed     Text format     Abstract available


  81. CHIU EC, Hung TM, Huang CM, Lee SC, et al
    Responsiveness of the Personal and Social Performance scale in patients with schizophrenia.
    Psychiatry Res. 2017;260:338-342.
    PubMed     Text format     Abstract available


  82. PAROLA A, Berardinelli L, Bosco FM
    Cognitive abilities and theory of mind in explaining communicative-pragmatic disorders in patients with schizophrenia.
    Psychiatry Res. 2017;260:144-151.
    PubMed     Text format     Abstract available


  83. SHARMA A, Kumar A, Singh S, Bhatia T, et al
    Altered resting state functional connectivity in early course schizophrenia.
    Psychiatry Res. 2017;271:17-23.
    PubMed     Text format     Abstract available


  84. DOMANY Y, Levy A, Cassan SM, Tarrasch R, et al
    Clinical utility of biomarkers of the hand in the diagnosis of schizophrenia.
    Psychiatry Res. 2017;260:105-110.
    PubMed     Text format     Abstract available


  85. ALLOTT KA, Yuen HP, Bartholomeusz CF, Rapado-Castro M, et al
    Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis.
    Psychiatry Res. 2017;260:60-66.
    PubMed     Text format     Abstract available


  86. VINGERHOETS C, Bloemen OJN, Boot E, Bakker G, et al
    Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis.
    Psychiatry Res. 2017 Nov 21. pii: S0925-4927(17)30192.
    PubMed     Text format     Abstract available


  87. CROCA M, Lagodka A, Gadel R, Bourdel MC, et al
    Theory of mind and schizophrenia in young and middle-aged patients: Influence of executive functions.
    Psychiatry Res. 2017;259:532-537.
    PubMed     Text format     Abstract available


  88. GUR S, Weizman S, Stubbs B, Matalon A, et al
    Mortality, morbidity and medical resources utilization of patients with schizophrenia: A case-control community-based study.
    Psychiatry Res. 2017;260:177-181.
    PubMed     Text format     Abstract available


  89. SUN Q, Huang X, Niu W, Yu T, et al
    The promoter polymorphisms in HTR2A gene associated with schizophrenia in Chinese of Han ethnicity.
    Psychiatry Res. 2017 Nov 15. pii: S0165-1781(17)30794.
    PubMed     Text format    


  90. RUZIBIZA C, Grattan RE, Eder R, Linscott RJ, et al
    Components of schizophrenia liability are not uniformly associated with stress sensitivity, resilience, and coping.
    Psychiatry Res. 2017;260:10-16.
    PubMed     Text format     Abstract available


  91. NOMURA I, Kishi T, Ikuta T, Iwata N, et al
    Statin add-on therapy in the antipsychotic treatment of schizophrenia: A meta-analysis.
    Psychiatry Res. 2017;260:41-47.
    PubMed     Text format     Abstract available


  92. PERLINI C, Bellani M, Finos L, Lasalvia A, et al
    Non literal language comprehension in a large sample of first episode psychosis patients in adulthood.
    Psychiatry Res. 2017;260:78-89.
    PubMed     Text format     Abstract available


  93. DAS S, Sengupta S, Pathak K, Sah D, et al
    Aggression as an independent entity even in psychosis - The role of cortisol.
    Psychiatry Res. 2017;259:405-411.
    PubMed     Text format     Abstract available


  94. VAN DIJK FA, Schirmbeck F, Haan L
    A longitudinal analysis of the effects of neuroticism and extraversion on subjective well-being in patients with schizophrenia.
    Psychiatry Res. 2017;259:538-544.
    PubMed     Text format     Abstract available


  95. CAO B, Sun XY, Zhang CB, Yan JJ, et al
    Association between B vitamins and schizophrenia: A population-based case-control study.
    Psychiatry Res. 2017;259:501-505.
    PubMed     Text format     Abstract available


  96. AHMED AO, Richardson J, Buckner A, Romanoff S, et al
    Do cognitive deficits predict negative emotionality and aggression in schizophrenia?
    Psychiatry Res. 2017;259:350-357.
    PubMed     Text format     Abstract available


  97. UNGPRASERT P, Wijarnpreecha K, Cheungpasitporn W
    Patients with schizophrenia have a higher risk of psoriasis: A systematic review and meta-analysis.
    Psychiatry Res. 2017;259:422-426.
    PubMed     Text format     Abstract available


  98. LANGEVELD J, Bjorkly S, Evensen J, Joa I, et al
    A 10-year follow-up study of violent victimization in first episode psychosis: Risk and protective factors.
    Psychiatry Res. 2017;259:545-549.
    PubMed     Text format     Abstract available


  99. DE LEON PP, Gerretsen P, Shah P, Saracco-Alvarez R, et al
    Cross-cultural psychometric assessment of the VAGUS insight into psychosis scale - Spanish version.
    Psychiatry Res. 2017;259:450-454.
    PubMed     Text format     Abstract available


    October 2017
  100. GSPANDL S, Peirson RP, Nahhas RW, Skale TG, et al
    Comparing Global Assessment of Functioning (GAF) and World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in schizophrenia.
    Psychiatry Res. 2017;259:251-253.
    PubMed     Text format     Abstract available


  101. LUBEIRO A, de Luis-Garcia R, Rodriguez M, Alvarez A, et al
    Biological and cognitive correlates of cortical curvature in schizophrenia.
    Psychiatry Res. 2017;270:68-75.
    PubMed     Text format     Abstract available


  102. GUIMOND S, Beland S, Lepage M
    Strategy for Semantic Association Memory (SESAME) training: Effects on brain functioning in schizophrenia.
    Psychiatry Res. 2017 Oct 25. pii: S0925-4927(17)30167.
    PubMed     Text format     Abstract available


  103. KRETCHY IA, Osafo J, Agyemang SA, Appiah B, et al
    Psychological burden and caregiver-reported non-adherence to psychotropic medications among patients with schizophrenia.
    Psychiatry Res. 2017;259:289-294.
    PubMed     Text format     Abstract available


  104. MUKERJI CE, Lincoln SH, Tully LM, Dodell-Feder D, et al
    Neural simulation mechanisms and social-emotional function in schizophrenia.
    Psychiatry Res. 2017 Oct 24. pii: S0925-4927(17)30101.
    PubMed     Text format     Abstract available


  105. MARTINELLI C, Rigoli F, Dolan RJ, Shergill SS, et al
    Decreased value-sensitivity in schizophrenia.
    Psychiatry Res. 2017;259:295-301.
    PubMed     Text format     Abstract available


  106. HIRASAWA-FUJITAA M, Tudor L, Nikolac Pekovic M, Kozumplik O, et al
    Genotypic and haplotypic associations of catechol-O-methyltransferase (COMT) rs4680 and rs4818 with salivary cortisol in patients with schizophrenia.
    Psychiatry Res. 2017;259:262-264.
    PubMed     Text format    


  107. DAUVERMANN MR, Moorhead TW, Watson AR, Duff B, et al
    Verbal working memory and functional large-scale networks in schizophrenia.
    Psychiatry Res. 2017;270:86-96.
    PubMed     Text format     Abstract available


  108. SELLERS R, Wells A, Parker S, Morrison AP, et al
    Do people with psychosis engage in unhelpful metacognitive coping strategies? A test of the validity of the Cognitive Attentional Syndrome (CAS) in a clinical sample.
    Psychiatry Res. 2017;259:243-250.
    PubMed     Text format     Abstract available


  109. JAJODIA A, Kaur H, Srivastava A, Kumari K, et al
    Schizophrenia susceptibility and neuregulin signaling pathway genes: A rare haplotype combination based association study in Indian population.
    Psychiatry Res. 2017 Oct 10. pii: S0165-1781(17)30253.
    PubMed     Text format    


  110. LIUHANEN J, Suvisaari J, Kajantie E, Miettunen J, et al
    Interaction between compound genetic risk for schizophrenia and high birth weight contributes to social anhedonia and schizophrenia in women.
    Psychiatry Res. 2017;259:148-153.
    PubMed     Text format     Abstract available


  111. LEE H, Kim HK, Kwon JT, Park S, et al
    BBOX1 is down-regulated in maternal immune-activated mice and implicated in genetic susceptibility to human schizophrenia.
    Psychiatry Res. 2017;259:197-202.
    PubMed     Text format     Abstract available


  112. SUBRAMANIAM A, Danivas V, Mahavir Agarwal S, Kalmady S, et al
    Clinical correlates of saccadic eye movement in antipsychotic-naive schizophrenia.
    Psychiatry Res. 2017;259:154-159.
    PubMed     Text format     Abstract available


  113. CHEN GF, Liu LL, Cui JF, Chen T, et al
    Life review therapy enhances mental time travel in patients with schizophrenia.
    Psychiatry Res. 2017;258:145-152.
    PubMed     Text format     Abstract available


  114. RUIZ JC, Soler MJ, Dasi C, Fuentes I, et al
    The effect of associative strength on semantic priming in schizophrenia.
    Psychiatry Res. 2017;259:1-6.
    PubMed     Text format     Abstract available


  115. CAMPELLONE TR, Kring AM
    Anticipated pleasure for positive and negative social interaction outcomes in schizophrenia.
    Psychiatry Res. 2017;259:203-209.
    PubMed     Text format     Abstract available


  116. JEONG SH, Chung IW, Jung HY, Hwang SS, et al
    Comparison of clinician-rated and self-report insight in Korean patients with schizophrenia using VAGUS insight scale.
    Psychiatry Res. 2017;258:93-100.
    PubMed     Text format     Abstract available


    September 2017
  117. DANAHER H, Allott K, Killackey E, Hester R, et al
    An examination of sex differences in neurocognition and social cognition in first-episode psychosis.
    Psychiatry Res. 2017;259:36-43.
    PubMed     Text format     Abstract available


  118. CREMASCHI L, Kardell M, Johansson V, Isgren A, et al
    Prevalences of autoimmune diseases in schizophrenia, bipolar I and II disorder, and controls.
    Psychiatry Res. 2017;258:9-14.
    PubMed     Text format     Abstract available


  119. ERDENIZ B, Serin E, Ibadi Y, Tas C, et al
    Decreased functional connectivity in schizophrenia: The relationship between social functioning, social cognition and graph theoretical network measures.
    Psychiatry Res. 2017;270:22-31.
    PubMed     Text format     Abstract available


  120. BELAND S, Lepage M
    The relative contributions of social cognition and self-reflectiveness to clinical insight in enduring schizophrenia.
    Psychiatry Res. 2017;258:116-123.
    PubMed     Text format     Abstract available


  121. TSUI MCM, Tsang HWH
    Views of people with schizophrenia and their caregivers towards the needs for psychiatric rehabilitation in urban and rural areas of mainland China.
    Psychiatry Res. 2017;258:72-77.
    PubMed     Text format     Abstract available


  122. FUJIMAKI K, Toki S, Yamashita H, Oyamada T, et al
    Predictors of negative symptoms in the chronic phase of schizophrenia: A cross-sectional study.
    Psychiatry Res. 2017 Sep 24. pii: S0165-1781(17)30729.
    PubMed     Text format     Abstract available


  123. VITOLO E, Tatu MK, Pignolo C, Cauda F, et al
    White matter and schizophrenia: A meta-analysis of voxel-based morphometry and diffusion tensor imaging studies.
    Psychiatry Res. 2017;270:8-21.
    PubMed     Text format     Abstract available


  124. DOROFEIKOVA M, Neznanov N, Petrova N
    Cognitive deficit in patients with paranoid schizophrenia: Its clinical and laboratory correlates.
    Psychiatry Res. 2017 Sep 20. pii: S0165-1781(17)31459.
    PubMed     Text format     Abstract available


  125. CUESTA MJ, Lecumberri P, Cabada T, Moreno-Izco L, et al
    Basal ganglia and ventricle volume in first-episode psychosis. A family and clinical study.
    Psychiatry Res. 2017;269:90-96.
    PubMed     Text format     Abstract available


  126. MELBOURNE JK, Chase KA, Feiner B, Rosen C, et al
    Long non-coding and endogenous retroviral RNA levels are associated with proinflammatory cytokine mRNA expression in peripheral blood cells: Implications for schizophrenia.
    Psychiatry Res. 2017 Sep 14. pii: S0165-1781(16)32171.
    PubMed     Text format     Abstract available


  127. BRIGHT M, Parker S, French P, Fowler D, et al
    Metacognitive beliefs as psychological predictors of social functioning: An investigation with young people at risk of psychosis.
    Psychiatry Res. 2017 Sep 14. pii: S0165-1781(17)30197.
    PubMed     Text format     Abstract available


  128. CONTRERAS NA, Tan EJ, Lee SJ, Castle DJ, et al
    Using visual processing training to enhance standard cognitive remediation outcomes in schizophrenia: A pilot study.
    Psychiatry Res. 2017 Sep 14. pii: S0165-1781(16)30805.
    PubMed     Text format     Abstract available


  129. RATHEE R, Luhrmann TM, Bhatia T, Deshpande SN, et al
    Cognitive insight and objective quality of life in people with schizophrenia and auditory hallucinations.
    Psychiatry Res. 2017;259:223-228.
    PubMed     Text format     Abstract available


  130. FRESAN A, Robles-Garcia R, Madrigal E, Tovilla-Zarate CA, et al
    Demographic and clinical features related to perceived discrimination in schizophrenia.
    Psychiatry Res. 2017 Sep 9. pii: S0165-1781(17)30314.
    PubMed     Text format     Abstract available


  131. VANCAMPFORT D, Gorczynski P, De Hert M, Probst M, et al
    Exercise self-efficacy correlates in people with psychosis.
    Psychiatry Res. 2017 Sep 8. pii: S0165-1781(17)30413.
    PubMed     Text format     Abstract available


  132. CATHERINE FA, Aurelie V, Eric G, Pierre M, et al
    Defining functioning levels in patients with schizophrenia: A combination of a novel clustering method and brain SPECT analysis.
    Psychiatry Res. 2017;270:32-38.
    PubMed     Text format     Abstract available


  133. KILICASLAN EE, Esen AT, Kasal MI, Ozelci E, et al
    Childhood trauma, depression, and sleep quality and their association with psychotic symptoms and suicidality in schizophrenia.
    Psychiatry Res. 2017 Sep 7. pii: S0165-1781(17)30902.
    PubMed     Text format     Abstract available


  134. MORENO-SAMANIEGO L, Gaviria AM, Vilella E, Valero J, et al
    Schizotypal traits and cognitive performance in siblings of patients with psychosis.
    Psychiatry Res. 2017 Sep 7. pii: S0165-1781(17)30539.
    PubMed     Text format     Abstract available


  135. WATSON AJ, Joyce EM, Fugard AJB, Leeson VC, et al
    More haste less speed: A meta-analysis of thinking latencies during planning in people with psychosis.
    Psychiatry Res. 2017 Sep 5. pii: S0165-1781(17)30175.
    PubMed     Text format     Abstract available


    August 2017
  136. LINDGREN M, Mantyla T, Rikandi E, Torniainen-Holm M, et al
    Childhood adversities and clinical symptomatology in first-episode psychosis.
    Psychiatry Res. 2017 Aug 26. pii: S0165-1781(17)30756.
    PubMed     Text format     Abstract available


  137. NIIMURA J, Nakanishi M, Yamasaki S, Nishida A, et al
    Regional supply of outreach service and length of stay in psychiatric hospital among patients with schizophrenia: National case mix data analysis in Japan.
    Psychiatry Res. 2017 Aug 24. pii: S0165-1781(16)32185.
    PubMed     Text format     Abstract available


  138. REMPFER MV, McDowd JM, Brown CE
    Measuring learning potential in people with schizophrenia: A comparison of two tasks.
    Psychiatry Res. 2017 Aug 24. pii: S0165-1781(17)30544.
    PubMed     Text format     Abstract available


  139. BO Q, Li F, Li X, Wang Z, et al
    Symptomatic remission in schizophrenia: Results from a risperidone maintenance treatment study.
    Psychiatry Res. 2017 Aug 24. pii: S0165-1781(16)31337.
    PubMed     Text format     Abstract available


  140. WU C, Dagg P, Molgat C
    Measuring stability of cognitive impairment in inpatients with schizophrenia with alternate forms of the Montreal Cognitive Assessment during acute hospitalization.
    Psychiatry Res. 2017 Aug 24. pii: S0165-1781(17)30592.
    PubMed     Text format     Abstract available


  141. SU CT, Yang AL, Lin CY
    Comparing two schizophrenia-specific quality of life instruments in institutionalized people with schizophrenia.
    Psychiatry Res. 2017 Aug 23. pii: S0165-1781(17)30674.
    PubMed     Text format     Abstract available


  142. AGAY N, Flaks-Manov N, Nitzan U, Hoshen MB, et al
    Cancer prevalence in men and women with schizophrenia.
    Psychiatry Res. 2017 Aug 19. pii: S0165-1781(17)30123.
    PubMed     Text format     Abstract available


  143. POS K, de Wit IE, van Dijk FA, Bartels-Velthuis AA, et al
    An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibility.
    Psychiatry Res. 2017 Aug 18. pii: S0165-1781(16)31386.
    PubMed     Text format     Abstract available


  144. CHIU YL, Lin HC, Kao NW, Kao S, et al
    Increased risk of concurrent hepatitis C among Male patients with schizophrenia.
    Psychiatry Res. 2017 Aug 18. pii: S0165-1781(16)31998.
    PubMed     Text format     Abstract available


  145. CHEN KW, Lee SC, Chiang HY, Syu YC, et al
    Psychometric properties of three measures assessing advanced theory of mind: Evidence from people with schizophrenia.
    Psychiatry Res. 2017;257:490-496.
    PubMed     Text format     Abstract available


  146. JIANG T, Zong L, Zhou L, Hou Y, et al
    Variation in global DNA hydroxymethylation with age associated with schizophrenia.
    Psychiatry Res. 2017;257:497-500.
    PubMed     Text format     Abstract available


  147. ANDERSON AE, Mansolf M, Reise SP, Savitz A, et al
    Measuring pathology using the PANSS across diagnoses: Inconsistency of the positive symptom domain across schizophrenia, schizoaffective, and bipolar disorder.
    Psychiatry Res. 2017 Aug 16. pii: S0165-1781(16)31411.
    PubMed     Text format     Abstract available


  148. WESTERMANN S, Grezellschak S, Oravecz Z, Moritz S, et al
    Untangling the complex relationships between symptoms of schizophrenia and emotion dynamics in daily life: Findings from an experience sampling pilot study.
    Psychiatry Res. 2017;257:514-518.
    PubMed     Text format     Abstract available


  149. HUANG H, Shu C, Chen J, Zou J, et al
    Altered corticostriatal pathway in first-episode paranoid schizophrenia: Resting-state functional and causal connectivity analyses.
    Psychiatry Res. 2017 Aug 15. pii: S0925-4927(17)30093.
    PubMed     Text format     Abstract available


  150. HSWEN Y, Naslund JA, Chandrashekar P, Siegel R, et al
    Exploring online communication about cigarette smoking among Twitter users who self-identify as having schizophrenia.
    Psychiatry Res. 2017;257:479-484.
    PubMed     Text format     Abstract available


  151. VADHAN NP, Corcoran CM, Bedi G, Keilp JG, et al
    Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study.
    Psychiatry Res. 2017;257:372-374.
    PubMed     Text format     Abstract available


  152. LYSAKER PH, George S, Chaudoin-Patzoldt KA, Pec O, et al
    Contrasting metacognitive, social cognitive and alexithymia profiles in adults with borderline personality disorder, schizophrenia and substance use disorder.
    Psychiatry Res. 2017;257:393-399.
    PubMed     Text format     Abstract available


  153. FAVROD O, Sierro G, Roinishvili M, Chkonia E, et al
    Electrophysiological correlates of visual backward masking in high schizotypic personality traits participants.
    Psychiatry Res. 2017;254:251-257.
    PubMed     Text format     Abstract available


  154. WANG YY, Shi HS, Liu WH, Yan C, et al
    Invariance of factor structure of the 21-item Peters et al. Delusions Inventory (PDI-21) over time and across samples.
    Psychiatry Res. 2017;254:190-197.
    PubMed     Text format     Abstract available


    July 2017
  155. TESSIER A, Boyer L, Husky M, Bayle F, et al
    Medication adherence in schizophrenia: The role of insight, therapeutic alliance and perceived trauma associated with psychiatric care.
    Psychiatry Res. 2017;257:315-321.
    PubMed     Text format     Abstract available


  156. ABRAHAMSE E, Ruitenberg M, Boddewyn S, Oreel E, et al
    Conflict adaptation in patients diagnosed with schizophrenia.
    Psychiatry Res. 2017;257:260-264.
    PubMed     Text format     Abstract available


  157. WILKINS LK, Girard TA, Herdman KA, Christensen BK, et al
    Hippocampal activation and memory in schizophrenia depend on spatial strategy use in a virtual maze.
    Psychiatry Res. 2017;268:1-8.
    PubMed     Text format     Abstract available


  158. TULLY S, Wells A, Morrison AP
    Attentional avoidance increases voice hearing in an analogue task in people with psychosis: An experimental study.
    Psychiatry Res. 2017;257:186-192.
    PubMed     Text format     Abstract available


  159. VERAS AB, Cougo S, Meira F, Peixoto C, et al
    Schizophrenia dissection by five anxiety and depressive subtype comorbidities: Clinical implications and evolutionary perspective.
    Psychiatry Res. 2017;257:172-178.
    PubMed     Text format     Abstract available


  160. SMIRNOVA D, Clark M, Jablensky A, Badcock JC, et al
    Action (verb) fluency deficits in schizophrenia spectrum disorders: linking language, cognition and interpersonal functioning.
    Psychiatry Res. 2017;257:203-211.
    PubMed     Text format     Abstract available


  161. DEMRO C, Rowland L, Wijtenburg SA, Waltz J, et al
    Glutamatergic metabolites among adolescents at risk for psychosis.
    Psychiatry Res. 2017;257:179-185.
    PubMed     Text format     Abstract available


  162. LI H, Shen Y, Wang G, Shi J, et al
    A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizop
    Psychiatry Res. 2017;259:117-124.
    PubMed     Text format     Abstract available


  163. SU YA, Yan F, Li Q, Xiang YT, et al
    Anticholinergic use trends in 14,013 patients with schizophrenia from three national surveys on the use of psychotropic medications in China (2002-2012).
    Psychiatry Res. 2017;257:132-136.
    PubMed     Text format     Abstract available


  164. HILL K, Bolo N, Sarvode Mothi S, Lizano P, et al
    Subcortical surface shape in youth at familial high risk for schizophrenia.
    Psychiatry Res. 2017;267:36-44.
    PubMed     Text format     Abstract available


  165. POPOLO R, Smith E, Lysaker PH, Lestingi K, et al
    Metacognitive profiles in schizophrenia and bipolar disorder: Comparisons with healthy controls and correlations with negative symptoms.
    Psychiatry Res. 2017;257:45-50.
    PubMed     Text format     Abstract available


  166. MANOUILENKO I, Humble MB, Georgieva J, Bejerot S, et al
    Brainstem Auditory Evoked Potentials for diagnosing Autism Spectrum Disorder, ADHD and Schizophrenia Spectrum Disorders in adults. A blinded study.
    Psychiatry Res. 2017;257:21-26.
    PubMed     Text format     Abstract available


  167. SKIBINSKA M, Kapelski P, Pawlak J, Rajewska-Rager A, et al
    Glial Cell Line-Derived Neurotrophic Factor (GDNF) serum level in women with schizophrenia and depression, correlation with clinical and metabolic parameters.
    Psychiatry Res. 2017;256:396-402.
    PubMed     Text format     Abstract available


  168. TRIXLER D, Tenyi T
    Iris structure and minor physical anomalies in schizophrenia.
    Psychiatry Res. 2017;256:412-416.
    PubMed     Text format     Abstract available


  169. PETRIKIS P, Voulgari PV, Tzallas AT, Boumba VA, et al
    Changes in the cytokine profile in first-episode, drug-naive patients with psychosis after short-term antipsychotic treatment.
    Psychiatry Res. 2017;256:378-383.
    PubMed     Text format     Abstract available


  170. KULKARNI K, Arasappa R, Prasad M K, Zutshi A, et al
    Risperidone versus olanzapine in the acute treatment of Persistent Delusional Disorder: A retrospective analysis.
    Psychiatry Res. 2017;253:270-273.
    PubMed     Text format     Abstract available


    June 2017
  171. ROSSI A, Galderisi S, Rocca P, Bertolino A, et al
    Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma.
    Psychiatry Res. 2017;256:359-364.
    PubMed     Text format     Abstract available


  172. WEISMAN DE MAMANI A, Weintraub MJ, Maura J, Martinez de Andino A, et al
    Acculturation styles and their associations with psychiatric symptoms and quality of life in ethnic minorities with schizophrenia.
    Psychiatry Res. 2017;255:418-423.
    PubMed     Text format     Abstract available


  173. HARROW M, Jobe TH, Faull RN, Yang J, et al
    A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.
    Psychiatry Res. 2017;256:267-274.
    PubMed     Text format     Abstract available


  174. WANG Y, Wang Y, Zhao Q, Cui JF, et al
    Preliminary study of visual perspective in mental time travel in schizophrenia.
    Psychiatry Res. 2017;256:225-227.
    PubMed     Text format     Abstract available


  175. LEE HS, Jang SK, Lee GY, Park SC, et al
    Informationally administered reward enhances intrinsic motivation in schizophrenia.
    Psychiatry Res. 2017;256:290-297.
    PubMed     Text format     Abstract available


  176. KISHI T, Inada K, Matsui Y, Iwata N, et al
    Z-drug for schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2017;256:365-370.
    PubMed     Text format     Abstract available


  177. LANGDON R, Connors M, Connaughton E
    Indirect task instructions better reveal theory-of-mind impairment, independent of executive dysfunction, in schizophrenia.
    Psychiatry Res. 2017;256:342-344.
    PubMed     Text format     Abstract available


  178. CASTRO-DE-ARAUJO LFS, Kanaan RAA
    First episode psychosis moderates the effect of gray matter volume on cognition.
    Psychiatry Res. 2017;266:108-113.
    PubMed     Text format     Abstract available


  179. SHE S, Zhang B, Li X, Zhang X, et al
    Face-related visual search deficits in first-episode schizophrenia.
    Psychiatry Res. 2017;256:144-149.
    PubMed     Text format     Abstract available


  180. HANLON MC, Campbell LE, Single N, Coleman C, et al
    Men and women with psychosis and the impact of illness-duration on sex-differences: The second Australian national survey of psychosis.
    Psychiatry Res. 2017;256:130-143.
    PubMed     Text format     Abstract available


  181. MANSUETO G, Faravelli C
    Recent life events and psychosis: The role of childhood adversities.
    Psychiatry Res. 2017;256:111-117.
    PubMed     Text format     Abstract available


  182. PERRY BI, Salimkumar D, Green D, Meakin A, et al
    Associated illness severity in schizophrenia and diabetes mellitus: A systematic review.
    Psychiatry Res. 2017;256:102-110.
    PubMed     Text format     Abstract available


  183. OKUBO R, Inoue T, Hashimoto N, Suzukawa A, et al
    The mediator effect of personality traits on the relationship between childhood abuse and depressive symptoms in schizophrenia.
    Psychiatry Res. 2017;257:126-131.
    PubMed     Text format     Abstract available


  184. HUANG ACW, Bo-Han He A, Chen CC
    An examination of the roles of glutamate and sex in latent inhibition: Relevance to the glutamate hypothesis of schizophrenia?
    Psychiatry Res. 2017;256:46-52.
    PubMed     Text format     Abstract available


  185. HOFER A, Radner V, Edlinger M, Kemmler G, et al
    Why do indiviuals with schizophrenia drop out of observational clinical trials?
    Psychiatry Res. 2017;256:1-5.
    PubMed     Text format     Abstract available


  186. CALDANI S, Amado I, Bendjemaa N, Vialatte F, et al
    Oculomotricity and Neurological Soft Signs: Can we refine the endophenotype? A study in subjects belonging to the spectrum of schizophrenia.
    Psychiatry Res. 2017;256:490-497.
    PubMed     Text format     Abstract available


  187. RAPP C, Canela C, Studerus E, Walter A, et al
    Duration of untreated psychosis/illness and brain volume changes in early psychosis.
    Psychiatry Res. 2017;255:332-337.
    PubMed     Text format     Abstract available


  188. KARPOUZIAN TM, Schroeder MP, Abram SV, Wanar H, et al
    Neural correlates of preserved facial affect perception in high functioning schizophrenia.
    Psychiatry Res. 2017;266:83-85.
    PubMed     Text format     Abstract available


  189. SURMANN M, Gruchalla LV, Falke S, Maisch B, et al
    The importance of strengthening competence and control beliefs in patients with psychosis to reduce treatment hindering self-stigmatization.
    Psychiatry Res. 2017;255:314-320.
    PubMed     Text format     Abstract available


    May 2017
  190. CANAL-RIVERO M, Lopez-Morinigo JD, Barrigon ML, Perona-Garcelan S, et al
    The role of premorbid personality and social cognition in suicidal behaviour in first-episode psychosis: A one-year follow-up study.
    Psychiatry Res. 2017;256:13-20.
    PubMed     Text format     Abstract available


  191. GABRIEL D, Jakubovski E, Taylor JH, Artukoglu BB, et al
    Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study.
    Psychiatry Res. 2017;255:248-255.
    PubMed     Text format     Abstract available


  192. BJORNESTAD J, Hegelstad WTV, Joa I, Davidson L, et al
    "With a little help from my friends" social predictors of clinical recovery in first-episode psychosis.
    Psychiatry Res. 2017;255:209-214.
    PubMed     Text format     Abstract available


  193. LI J, Guo YB, Huang YG, Liu JW, et al
    Stigma and discrimination experienced by people with schizophrenia living in the community in Guangzhou, China.
    Psychiatry Res. 2017;255:225-231.
    PubMed     Text format     Abstract available


  194. TIMUCIN OB, Mutlu EA, Timucin D, Aslanci ME, et al
    Psychophysical assessment of koniocellular pathway in patients with schizophrenia versus healthy controls.
    Psychiatry Res. 2017;266:27-34.
    PubMed     Text format     Abstract available


  195. NENADIC I, Hoof A, Dietzek M, Langbein K, et al
    Diffusion tensor imaging of cingulum bundle and corpus callosum in schizophrenia vs. bipolar disorder.
    Psychiatry Res. 2017;266:96-100.
    PubMed     Text format     Abstract available


  196. NENADIC I, Dietzek M, Langbein K, Sauer H, et al
    BrainAGE score indicates accelerated brain aging in schizophrenia, but not bipolar disorder.
    Psychiatry Res. 2017;266:86-89.
    PubMed     Text format     Abstract available


  197. PRISTED SG, Correll CU, Nielsen J
    Frequency and correlates of anticholinergic use among patients with schizophrenia in Denmark: A Nation-wide pharmacoepidemiological study.
    Psychiatry Res. 2017;255:198-203.
    PubMed     Text format     Abstract available


  198. TAKAHASHI T, Takayanagi Y, Nishikawa Y, Nakamura M, et al
    Brain neurodevelopmental markers related to the deficit subtype of schizophrenia.
    Psychiatry Res. 2017;266:10-18.
    PubMed     Text format     Abstract available


  199. HUHTANISKA S, Jaaskelainen E, Heikka T, Moilanen JS, et al
    Long-term antipsychotic and benzodiazepine use and brain volume changes in schizophrenia: The Northern Finland Birth Cohort 1966 study.
    Psychiatry Res. 2017;266:73-82.
    PubMed     Text format     Abstract available


  200. CARNEY R, Cotter J, Bradshaw T, Yung AR, et al
    Examining the physical health and lifestyle of young people at ultra-high risk for psychosis: A qualitative study involving service users, parents and clinicians.
    Psychiatry Res. 2017;255:87-93.
    PubMed     Text format     Abstract available


  201. FLAHERTY LR, Daniels K, Luther J, Haas GL, et al
    Reduction of medical hospitalizations in veterans with schizophrenia using home telehealth.
    Psychiatry Res. 2017;255:153-155.
    PubMed     Text format     Abstract available


  202. SCHOELER T, Petros N, Di Forti M, Klamerus E, et al
    Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis.
    Psychiatry Res. 2017;255:36-41.
    PubMed     Text format     Abstract available


  203. WOOD L, Byrne R, Burke E, Enache G, et al
    The impact of stigma on emotional distress and recovery from psychosis: The mediatory role of internalised shame and self-esteem.
    Psychiatry Res. 2017;255:94-100.
    PubMed     Text format     Abstract available


  204. BOUAZIZ N, Moulier V, Lettelier-Galle T, Osmond I, et al
    Impact of reward on pain threshold and tolerance to experimental pain (Cold Pressor Task) in healthy subjects and patients with schizophrenia.
    Psychiatry Res. 2017;254:275-278.
    PubMed     Text format    


  205. BIAGIARELLI M, Curto M, Di Pomponio I, Comparelli A, et al
    Antipsychotic treatment and the Rorschach Perceptual Thinking Index (PTI) in psychotic disorder patients: Effects of treatment.
    Psychiatry Res. 2017;251:294-297.
    PubMed     Text format     Abstract available


    April 2017
  206. TERACHI S, Yamada T, Pu S, Yokoyama K, et al
    Comparison of neurocognitive function in major depressive disorder, bipolar disorder, and schizophrenia in later life: A cross-sectional study of euthymic or remitted, non-demented patients using the Japanese version of the Brief Assessment of Cogniti
    Psychiatry Res. 2017;254:205-210.
    PubMed     Text format     Abstract available


  207. GARRIDO G, Penades R, Barrios M, Aragay N, et al
    Computer-assisted cognitive remediation therapy in schizophrenia: Durability of the effects and cost-utility analysis.
    Psychiatry Res. 2017;254:198-204.
    PubMed     Text format     Abstract available


  208. ISHIWATA S, Hattori K, Sasayama D, Teraishi T, et al
    Plasma and cerebrospinal fluid G72 protein levels in schizophrenia and major depressive disorder.
    Psychiatry Res. 2017;254:244-250.
    PubMed     Text format     Abstract available


  209. SHE S, Deng Y, Chen Y, Wu C, et al
    Two-stage integrated care versus antipsychotic medication alone on outcomes of schizophrenia: One-year randomized controlled trial and follow-up.
    Psychiatry Res. 2017;254:164-172.
    PubMed     Text format     Abstract available


  210. DEMPSTER K, Norman R, Theberge J, Densmore M, et al
    Cognitive performance is associated with gray matter decline in first-episode psychosis.
    Psychiatry Res. 2017;264:46-51.
    PubMed     Text format     Abstract available


  211. GUO W, Liu F, Chen J, Wu R, et al
    Using short-range and long-range functional connectivity to identify schizophrenia with a family-based case-control design.
    Psychiatry Res. 2017;264:60-67.
    PubMed     Text format     Abstract available


  212. ERTEKIN E, Ucok A, Keskin-Ergen Y, Devrim-Ucok M, et al
    Deficits in Go and NoGo P3 potentials in patients with schizophrenia.
    Psychiatry Res. 2017;254:126-132.
    PubMed     Text format     Abstract available


  213. SIMONSEN C, Faerden A, Romm KL, Berg AO, et al
    Early clinical recovery in first-episode psychosis: Symptomatic remission and its correlates at 1-year follow-up.
    Psychiatry Res. 2017;254:118-125.
    PubMed     Text format     Abstract available


  214. LI Y, Hou CL, Ma XR, Zhong BL, et al
    Quality of life in Chinese patients with schizophrenia treated in primary care.
    Psychiatry Res. 2017;254:80-84.
    PubMed     Text format     Abstract available


  215. GALLETTI C, Paolini E, Tortorella A, Compton MT, et al
    Auditory and non-auditory hallucinations in first-episode psychosis: Differential associations with diverse clinical features.
    Psychiatry Res. 2017;254:268-274.
    PubMed     Text format     Abstract available


  216. TSOTSI S, Kosmidis MH, Bozikas VP
    Improved facial affect recognition in schizophrenia following an emotion intervention, but not training attention-to-facial-features or treatment-as-usual.
    Psychiatry Res. 2017;254:135-142.
    PubMed     Text format     Abstract available


  217. DA SILVA S, Saperia S, Siddiqui I, Fervaha G, et al
    Investigating consummatory and anticipatory pleasure across motivation deficits in schizophrenia and healthy controls.
    Psychiatry Res. 2017;254:112-117.
    PubMed     Text format     Abstract available


  218. OHMURO N, Matsumoto K, Ishii Y, Katsura M, et al
    The associations between quality of life and clinical symptoms in individuals with an at-risk mental state and first-episode psychosis.
    Psychiatry Res. 2017;254:54-59.
    PubMed     Text format     Abstract available


  219. ARMANDO M, Lin A, Pontillo M, Vicari S, et al
    Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning.
    Psychiatry Res. 2017;254:238-243.
    PubMed     Text format     Abstract available


  220. FOND G, Godin O, Boyer L, Llorca PM, et al
    Advanced paternal age is associated with earlier schizophrenia onset in offspring. Results from the national multicentric FACE-SZ cohort.
    Psychiatry Res. 2017;254:218-223.
    PubMed     Text format     Abstract available


  221. ORLIAC F, Delamillieure P, Delcroix N, Naveau M, et al
    Network modeling of resting state connectivity points towards the bottom up theories of schizophrenia.
    Psychiatry Res. 2017;266:19-26.
    PubMed     Text format     Abstract available


  222. BELGE JB, Maurage P, Mangelinckx C, Leleux D, et al
    Facial decoding in schizophrenia is underpinned by basic visual processing impairments.
    Psychiatry Res. 2017;255:167-172.
    PubMed     Text format     Abstract available


  223. LO CASCIO N, Curto M, Pasqualetti P, Lindau JF, et al
    Impairment in Social Functioning differentiates youth meeting Ultra-High Risk for psychosis criteria from other mental health help-seekers: A validation of the Italian version of the Global Functioning: Social and Global Functioning: Role scales.
    Psychiatry Res. 2017;253:296-302.
    PubMed     Text format     Abstract available


  224. COENTRE R, Talina MC, Gois C, Figueira ML, et al
    Depressive symptoms and suicidal behavior after first-episode psychosis: A comprehensive systematic review.
    Psychiatry Res. 2017;253:240-248.
    PubMed     Text format     Abstract available


  225. RAVICHANDRAN C, Shinn AK, Ongur D, Perlis RH, et al
    Frequency of non-right-handedness in bipolar disorder and schizophrenia.
    Psychiatry Res. 2017;253:267-269.
    PubMed     Text format     Abstract available


  226. BAHORIK AL, Greeno CG, Cochran G, Cornelius JR, et al
    Motivation deficits and use of alcohol and illicit drugs among individuals with schizophrenia.
    Psychiatry Res. 2017;253:391-397.
    PubMed     Text format     Abstract available


  227. BORTOLON C, Capdevielle D, Altman R, Macgregor A, et al
    Mirror self-face perception in individuals with schizophrenia: Feelings of strangeness associated with one's own image.
    Psychiatry Res. 2017;253:205-210.
    PubMed     Text format     Abstract available


  228. HUMPSTON CS, Linden DEJ, Evans LH
    Deficits in reality and internal source monitoring of actions are associated with the positive dimension of schizotypy.
    Psychiatry Res. 2017;250:44-49.
    PubMed     Text format     Abstract available


    March 2017
  229. KALMADY SV, Shivakumar V, Arasappa R, Subramaniam A, et al
    Clinical correlates of hippocampus volume and shape in antipsychotic-naive schizophrenia.
    Psychiatry Res. 2017;263:93-102.
    PubMed     Text format     Abstract available


  230. WU XJ, Zeng LL, Shen H, Yuan L, et al
    Functional network connectivity alterations in schizophrenia and depression.
    Psychiatry Res. 2017;263:113-120.
    PubMed     Text format     Abstract available


  231. WANG C, Zhang Y
    Season of birth and schizophrenia: Evidence from China.
    Psychiatry Res. 2017;253:189-196.
    PubMed     Text format     Abstract available


  232. WUSTEN C, Lincoln TM
    The association of family functioning and psychosis proneness in five countries that differ in cultural values and family structures.
    Psychiatry Res. 2017;253:158-164.
    PubMed     Text format     Abstract available


  233. BOLL KM, Noto C, Bonifacio KL, Bortolasci CC, et al
    Oxidative and nitrosative stress biomarkers in chronic schizophrenia.
    Psychiatry Res. 2017;253:43-48.
    PubMed     Text format     Abstract available


  234. JAHSHAN C, Wolf M, Karbi Y, Shamir E, et al
    Probing the magnocellular and parvocellular visual pathways in facial emotion perception in schizophrenia.
    Psychiatry Res. 2017;253:38-42.
    PubMed     Text format     Abstract available


  235. FORNS-NADAL M, Berge D, Sem F, Mane A, et al
    Increased nucleus accumbens volume in first-episode psychosis.
    Psychiatry Res. 2017;263:57-60.
    PubMed     Text format     Abstract available


  236. RAFFARD S, Bortolon C, Stephan Y, Capdevielle D, et al
    Personality traits are associated with the valence of future imagined events in individuals with schizophrenia.
    Psychiatry Res. 2017;253:138-141.
    PubMed     Text format     Abstract available


  237. VANCAMPFORT D, De Hert M, Myin-Germeys I, van Winkel R, et al
    Lower cardiorespiratory fitness is associated with more time spent sedentary in first episode psychosis: A pilot study.
    Psychiatry Res. 2017;253:13-17.
    PubMed     Text format     Abstract available


  238. LUAN Z, Zhang D
    The anaplastic lymphoma kinase (ALK) gene is associated with schizophrenia in a Chinese population.
    Psychiatry Res. 2017 Mar 9. pii: S0165-1781(16)31996.
    PubMed     Text format    


  239. GROVER S, Sahoo S, Dua D, Chakrabarti S, et al
    Scales for assessment of depression in schizophrenia: Factor analysis of calgary depression rating scale and hamilton depression rating scale.
    Psychiatry Res. 2017;252:333-339.
    PubMed     Text format     Abstract available


  240. LARIVIERE S, Lavigne KM, Woodward TS, Gerretsen P, et al
    Altered functional connectivity in brain networks underlying self-referential processing in delusions of reference in schizophrenia.
    Psychiatry Res. 2017;263:32-43.
    PubMed     Text format     Abstract available


  241. BOLINSKEY PK, Smith EA, Schuder KM, Cooper-Bolinskey D, et al
    Schizophrenia spectrum personality disorders in psychometrically identified schizotypes at two-year follow-up.
    Psychiatry Res. 2017;252:289-295.
    PubMed     Text format     Abstract available


  242. YU LQ, Lee S, Katchmar N, Satterthwaite TD, et al
    Steeper discounting of delayed rewards in schizophrenia but not first-degree relatives.
    Psychiatry Res. 2017;252:303-309.
    PubMed     Text format     Abstract available


  243. CHU CS, Chow PC, Cohen-Woods S, Gaysina D, et al
    The DAOA gene is associated with schizophrenia in the Taiwanese population.
    Psychiatry Res. 2017;252:201-207.
    PubMed     Text format     Abstract available


  244. MI W, Zhang S, Liu Q, Yang F, et al
    Prevalence and risk factors of agitation in newly hospitalized schizophrenia patients in China: An observational survey.
    Psychiatry Res. 2017;253:401-406.
    PubMed     Text format     Abstract available


  245. RIBOLSI M, Lin A, Wardenaar KJ, Pontillo M, et al
    Clinical presentation of Attenuated Psychosis Syndrome in children and adolescents: Is there an age effect?
    Psychiatry Res. 2017;252:169-174.
    PubMed     Text format     Abstract available


    February 2017
  246. MASSONS C, Lopez-Morinigo JD, Pousa E, Ruiz A, et al
    Insight and suicidality in psychosis: A cross-sectional study.
    Psychiatry Res. 2017;252:147-153.
    PubMed     Text format     Abstract available


  247. BI Y, Huang X, Niu W, Chen S, et al
    No association between SLC6A2, SLC6A3, DRD2 polymorphisms and schizophrenia in the Han Chinese population.
    Psychiatry Res. 2017;253:398-400.
    PubMed     Text format     Abstract available


  248. MCCARTHY-JONES S, Smailes D, Corvin A, Gill M, et al
    Occurrence and co-occurrence of hallucinations by modality in schizophrenia-spectrum disorders.
    Psychiatry Res. 2017;252:154-160.
    PubMed     Text format     Abstract available


  249. PERRON M, Roy-Charland A, Dickinson J, LaForge C, et al
    The use of the Duchenne marker and symmetry of the expression in the judgment of smiles in schizophrenia.
    Psychiatry Res. 2017;252:126-133.
    PubMed     Text format     Abstract available


  250. FUNG CK, Moore MM, Karcher NR, Kerns JG, et al
    Emotional word usage in groups at risk for schizophrenia-spectrum disorders: An objective investigation of attention to emotion.
    Psychiatry Res. 2017;252:29-37.
    PubMed     Text format     Abstract available


  251. SHARMA A, Schray A, Bartolovic M, Roesch-Ely D, et al
    Relationship between serum calcium and neuropsychological performance might indicate etiological heterogeneity underlying cognitive deficits in schizophrenia and depression.
    Psychiatry Res. 2017;252:80-86.
    PubMed     Text format     Abstract available


  252. DUNNE PW, Roberts DL, Quinones MP, Velligan DI, et al
    Immune markers of social cognitive bias in schizophrenia.
    Psychiatry Res. 2017;251:319-324.
    PubMed     Text format     Abstract available


  253. GERRETSEN P, Pothier DD, Falls C, Armstrong M, et al
    Vestibular stimulation improves insight into illness in schizophrenia spectrum disorders.
    Psychiatry Res. 2017;251:333-341.
    PubMed     Text format     Abstract available


  254. MCKETIN R, Baker AL, Dawe S, Voce A, et al
    Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    Psychiatry Res. 2017;251:349-354.
    PubMed     Text format     Abstract available


  255. HERNIMAN SE, Allott KA, Killackey E, Hester R, et al
    The psychometric validity of the Center for Epidemiological Studies - Depression Scale (CES-D) in first episode schizophrenia spectrum.
    Psychiatry Res. 2017;252:16-22.
    PubMed     Text format     Abstract available


  256. BECHI M, Bosia M, Spangaro M, Buonocore M, et al
    Exploring functioning in schizophrenia: Predictors of functional capacity and real-world behaviour.
    Psychiatry Res. 2017;251:118-124.
    PubMed     Text format     Abstract available


  257. DARMEDRU C, Demily C, Franck N
    Cognitive remediation and social cognitive training for violence in schizophrenia: a systematic review.
    Psychiatry Res. 2017;251:266-274.
    PubMed     Text format     Abstract available


  258. FRANCIS MM, Hummer TA, Leonhardt BL, Vohs JL, et al
    Association of medial prefrontal resting state functional connectivity and metacognitive capacity in early phase psychosis.
    Psychiatry Res. 2017;262:8-14.
    PubMed     Text format     Abstract available


  259. HU TM, Hsu SH, Tsai SM, Cheng MC, et al
    DNA methylation analysis of the EGR3 gene in patients of schizophrenia.
    Psychiatry Res. 2017;251:115-117.
    PubMed     Text format     Abstract available


  260. TOPCUOGLU C, Bakirhan A, Yilmaz FM, Neselioglu S, et al
    Thiol/disulfide homeostasis in untreated schizophrenia patients.
    Psychiatry Res. 2017;251:212-216.
    PubMed     Text format     Abstract available


  261. VAN DEN NOORT M, Perriard B, Lim S, Bosch P, et al
    Why are self-rating results in patients with schizophrenia often unreliable?
    Psychiatry Res. 2017;251:76-77.
    PubMed     Text format    


  262. MALHERBE PJ, Karayiorgou M, Ehlers R, Roos JL, et al
    Increased risk of suicide in schizophrenia patients with linkage to chromosome 13q.
    Psychiatry Res. 2017;251:34-35.
    PubMed     Text format     Abstract available


  263. SCHULTZ CC, Wagner G, Schachtzabel C, Reichenbach JR, et al
    Increased white matter radial diffusivity is associated with prefrontal cortical folding deficits in schizophrenia.
    Psychiatry Res. 2017;261:91-95.
    PubMed     Text format     Abstract available


  264. BILGI MM, Taspinar S, Aksoy B, Oguz K, et al
    The relationship between childhood trauma, emotion recognition, and irritability in schizophrenia patients.
    Psychiatry Res. 2017;251:90-96.
    PubMed     Text format     Abstract available


  265. JANSEN JE, Lysaker PH, Trauelsen AM, Luther L, et al
    Metacognitive mastery in persons with first-episode psychosis and their caregivers: Implications for timely help-seeking and caregiver experiences. Brief report.
    Psychiatry Res. 2017;251:54-57.
    PubMed     Text format     Abstract available


  266. GERRETSEN P, Takeuchi H, Ozzoude M, Graff-Guerrero A, et al
    Insight into illness and its relationship to illness severity, cognition and estimated antipsychotic dopamine receptor occupancy in schizophrenia: An antipsychotic dose reduction study.
    Psychiatry Res. 2017;251:20-25.
    PubMed     Text format     Abstract available


  267. JAMES BO, Omoaregba JO, Raji SO, Imishue OE, et al
    Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy.
    Psychiatry Res. 2017;248:134-139.
    PubMed     Text format     Abstract available


    January 2017
  268. STEINAU S, Stegmayer K, Lang FU, Jager M, et al
    Comparison of psychopathological dimensions between major depressive disorder and schizophrenia spectrum disorders focusing on language, affectivity and motor behavior.
    Psychiatry Res. 2017;250:169-176.
    PubMed     Text format     Abstract available


  269. OTA M, Sato N, Hidese S, Teraishi T, et al
    Structural differences in hippocampal subfields among schizophrenia patients, major depressive disorder patients, and healthy subjects.
    Psychiatry Res. 2017;259:54-59.
    PubMed     Text format     Abstract available


  270. ALTAMURA AC, Delvecchio G, Paletta S, Di Pace C, et al
    Gray matter volumes may predict the clinical response to paliperidone palmitate long-acting in acute psychosis: A pilot longitudinal neuroimaging study.
    Psychiatry Res. 2017;261:80-84.
    PubMed     Text format     Abstract available


  271. GROVER S, Dua D, Chakrabarti S, Avasthi A, et al
    Obsessive Compulsive Symptoms/disorder in patients with schizophrenia: Prevalence, relationship with other symptom dimensions and impact on functioning.
    Psychiatry Res. 2017;250:277-284.
    PubMed     Text format     Abstract available


  272. YOSHIMURA B, Yada Y, So R, Takaki M, et al
    The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study.
    Psychiatry Res. 2017;250:65-70.
    PubMed     Text format     Abstract available


  273. GORCZYNSKI P, Firth J, Stubbs B, Rosenbaum S, et al
    Are people with schizophrenia adherent to diabetes medication? A comparative meta-analysis.
    Psychiatry Res. 2017;250:17-24.
    PubMed     Text format     Abstract available


  274. TAKAHASHI S, Suzuki M, Uchiyama M, Nakayama T, et al
    Replication study of de novo mutations of TAF13 in schizophrenia.
    Psychiatry Res. 2017 Jan 21. pii: S0165-1781(16)31460.
    PubMed     Text format    


  275. HUKIC DS, Lavebratt C, Olsson E, Ostenson CG, et al
    Troponin T levels associated with genetic variants in NOTCH2 and MTNR1B in women with psychosis.
    Psychiatry Res. 2017;250:217-220.
    PubMed     Text format     Abstract available


  276. MORERA-FUMERO AL, Diaz-Mesa E, Abreu-Gonzalez P, Fernandez-Lopez L, et al
    Low levels of serum total antioxidant capacity and presence at admission and absence at discharge of a day/night change as a marker of acute paranoid schizophrenia relapse.
    Psychiatry Res. 2017;249:200-205.
    PubMed     Text format     Abstract available


  277. HELLE S, Loberg EM, Gjestad R, Schnakenberg Martin AM, et al
    The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition.
    Psychiatry Res. 2017;250:92-98.
    PubMed     Text format     Abstract available


  278. MANE A, Berge D, Penzol MJ, Parellada M, et al
    Cannabis use, COMT, BDNF and age at first-episode psychosis.
    Psychiatry Res. 2017;250:38-43.
    PubMed     Text format     Abstract available


  279. GROVER S, Chakrabarti S, Hazari N, Avasthi A, et al
    Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study.
    Psychiatry Res. 2017;249:349-353.
    PubMed     Text format     Abstract available


  280. JIMENEZ AM, Lee J, Green MF, Wynn JK, et al
    Functional connectivity when detecting rare visual targets in schizophrenia.
    Psychiatry Res. 2017;261:35-43.
    PubMed     Text format     Abstract available


  281. ZHOU Y, Rosenheck R, Mohamed S, Ning Y, et al
    Factors associated with complete discontinuation of medication among patients with schizophrenia in the year after hospital discharge.
    Psychiatry Res. 2017;250:129-135.
    PubMed     Text format     Abstract available


  282. GOGHARI VM
    Personality dimensions in schizophrenia: A family study.
    Psychiatry Res. 2017;251:162-167.
    PubMed     Text format     Abstract available


  283. WANG J, Liu Q, Wydell TN, Liao J, et al
    Electrophysiological basis of reading related phonological impairment in Chinese speakers with schizophrenia: An ERP study.
    Psychiatry Res. 2017;261:65-71.
    PubMed     Text format     Abstract available


  284. FONG TC, Ho RT, Wan AH, Au-Yeung FS, et al
    Psychiatric symptoms mediate the effects of neurological soft signs on functional outcomes in patients with chronic schizophrenia: A longitudinal path-analytic study.
    Psychiatry Res. 2017;249:152-158.
    PubMed     Text format     Abstract available


  285. IASEVOLI F, Fagiolini A, Formato MV, Prinzivalli E, et al
    Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients.
    Psychiatry Res. 2017;249:159-166.
    PubMed     Text format     Abstract available


  286. KINCAID DL, Doris M, Shannon C, Mulholland C, et al
    What is the prevalence of autism spectrum disorder and ASD traits in psychosis? A systematic review.
    Psychiatry Res. 2017;250:99-105.
    PubMed     Text format     Abstract available


  287. MERRILL AM, Karcher NR, Cicero DC, Becker TM, et al
    Evidence that communication impairment in schizophrenia is associated with generalized poor task performance.
    Psychiatry Res. 2017;249:172-179.
    PubMed     Text format     Abstract available


  288. LI Z, Lei W, Deng W, Zheng Z, et al
    Aberrant spontaneous neural activity and correlation with evoked-brain potentials in first-episode, treatment-naive patients with deficit and non-deficit schizophrenia.
    Psychiatry Res. 2017;261:9-19.
    PubMed     Text format     Abstract available


  289. WEISS EM, Singewald E, Baldus C, Hofer E, et al
    Differences in psychological and somatic symptom cluster score profiles between subjects with Idiopathic environmental intolerance, major depression and schizophrenia.
    Psychiatry Res. 2017;249:187-194.
    PubMed     Text format     Abstract available


  290. DARRELL-BERRY H, Bucci S, Palmier-Claus J, Emsley R, et al
    Predictors and mediators of trait anger across the psychosis continuum: The role of attachment style, paranoia and social cognition.
    Psychiatry Res. 2017;249:132-138.
    PubMed     Text format     Abstract available


  291. ROBUSTELLI BL, Newberry RE, Whisman MA, Mittal VA, et al
    Social relationships in young adults at ultra high risk for psychosis.
    Psychiatry Res. 2017;247:345-351.
    PubMed     Text format     Abstract available


  292. KEGEL ME, Johansson V, Wetterberg L, Bhat M, et al
    Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity.
    Psychiatry Res. 2017;247:105-112.
    PubMed     Text format     Abstract available


  293. ENGEL M, Lincoln TM
    Concordance of self- and observer-rated motivation and pleasure in patients with negative symptoms and healthy controls.
    Psychiatry Res. 2017;247:1-5.
    PubMed     Text format     Abstract available


  294. FAGIOLINI A, Rocca P, De Giorgi S, Spina E, et al
    Clinical trial methodology to assess the efficacy/effectiveness of long-acting antipsychotics: Randomized controlled trials vs naturalistic studies.
    Psychiatry Res. 2017;247:257-264.
    PubMed     Text format     Abstract available


    December 2016
  295. YASUYAMA T, Ohi K, Shimada T, Uehara T, et al
    Differences in social functioning among patients with major psychiatric disorders: Interpersonal communication is impaired in patients with schizophrenia and correlates with an increase in schizotypal traits.
    Psychiatry Res. 2016;249:30-34.
    PubMed     Text format     Abstract available


  296. KWONG VW, Chang WC, Chan GH, Jim OT, et al
    Clinical and treatment-related determinants of subjective quality of life in patients with first-episode psychosis.
    Psychiatry Res. 2016;249:39-45.
    PubMed     Text format     Abstract available


  297. KAKELA J, Marttila R, Keskinen E, Veijola J, et al
    Association between family history of psychiatric disorders and long-term outcome in schizophrenia - The Northern Finland Birth Cohort 1966 study.
    Psychiatry Res. 2016;249:16-22.
    PubMed     Text format     Abstract available


  298. BONFILS KA, Lysaker PH, Minor KS, Salyers MP, et al
    Empathy in schizophrenia: A meta-analysis of the Interpersonal Reactivity Index.
    Psychiatry Res. 2016;249:293-303.
    PubMed     Text format     Abstract available


  299. LI Q, Du X, Zhang Y, Yin G, et al
    The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia.
    Psychiatry Res. 2016;251:131-136.
    PubMed     Text format     Abstract available


  300. KOCHS A, Kohler S, Merz H, Sterzer P, et al
    Effects of self and familiarity on change detection in patients with schizophrenia.
    Psychiatry Res. 2016;248:140-146.
    PubMed     Text format     Abstract available


  301. POE SL, Brucato G, Bruno N, Arndt LY, et al
    Sleep disturbances in individuals at clinical high risk for psychosis.
    Psychiatry Res. 2016;249:240-243.
    PubMed     Text format     Abstract available


  302. AYDIN E, Cansu Ulgen M, Tabo A, Devrim Balaban O, et al
    Executive function and genetic loading in nonpsychotic relatives of schizophrenia patients.
    Psychiatry Res. 2016;248:105-110.
    PubMed     Text format     Abstract available


  303. EL HAJ M, Altman R, Bortolon C, Capdevielle D, et al
    Destination memory in schizophrenia: "Did I told Elvis Presley about the thief?"
    Psychiatry Res. 2016;248:71-76.
    PubMed     Text format     Abstract available


  304. SON S, Miyata J, Mori Y, Isobe M, et al
    Lateralization of intrinsic frontoparietal network connectivity and symptoms in schizophrenia.
    Psychiatry Res. 2016;260:23-28.
    PubMed     Text format     Abstract available


  305. HSU WY, Muo CH, Ma SP, Kao CH, et al
    Association between schizophrenia and urinary incontinence: A population-based study.
    Psychiatry Res. 2016;248:35-39.
    PubMed     Text format     Abstract available


  306. CUI LB, Chen G, Xu ZL, Liu L, et al
    Cerebral blood flow and its connectivity features of auditory verbal hallucinations in schizophrenia: A perfusion study.
    Psychiatry Res. 2016;260:53-61.
    PubMed     Text format     Abstract available


  307. ANDORKO ND, Mittal V, Thompson E, Denenny D, et al
    The association between sleep dysfunction and psychosis-like experiences among college students.
    Psychiatry Res. 2016;248:6-12.
    PubMed     Text format     Abstract available


  308. CONRAD AM, Lewin TJ, Sly KA, Schall U, et al
    Utility of risk-status for predicting psychosis and related outcomes: evaluation of a 10-year cohort of presenters to a specialised early psychosis community mental health service.
    Psychiatry Res. 2016;247:336-344.
    PubMed     Text format     Abstract available


    November 2016
  309. BUCCI S, Emsley R, Berry K
    Attachment in psychosis: A latent profile analysis of attachment styles and association with symptoms in a large psychosis cohort.
    Psychiatry Res. 2016;247:243-249.
    PubMed     Text format     Abstract available


  310. DOMINGUEZ-MARTINEZ T, Medina-Pradas C, Kwapil TR, Barrantes-Vidal N, et al
    Relatives' expressed emotion, distress and attributions in clinical high-risk and recent onset of psychosis.
    Psychiatry Res. 2016;247:323-329.
    PubMed     Text format     Abstract available


  311. SCHURHOFF F, Leboyer M, Szoke A
    Comorbidity between schizophrenia and keratoconus.
    Psychiatry Res. 2016;247:315-316.
    PubMed     Text format    


  312. ALEGRE M, Molero P, Valencia M, Mayner G, et al
    A typical antipsychotics normalize low-gamma evoked oscillations in patients with schizophrenia.
    Psychiatry Res. 2016;247:214-221.
    PubMed     Text format     Abstract available


  313. BERHANU D, Mattiaccio LM, Antshel KM, Fremont W, et al
    Cortical-amygdala volumetric ratios predict onset of symptoms of psychosis in 22q11.2 deletion syndrome.
    Psychiatry Res. 2016;259:10-15.
    PubMed     Text format     Abstract available


  314. BAUP H, Verdoux H
    Frequency and pattern of Internet use in patients with schizophrenia or bipolar disorders seeking medical information.
    Psychiatry Res. 2016;247:152-154.
    PubMed     Text format     Abstract available


  315. TAKANO Y, Aoki Y, Yahata N, Kawakubo Y, et al
    Neural basis for inferring false beliefs and social emotions in others among individuals with schizophrenia and those at ultra-high risk for psychosis.
    Psychiatry Res. 2016;259:34-41.
    PubMed     Text format     Abstract available


  316. BAS A, Gultekin G, Incir S, Bas TO, et al
    Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics.
    Psychiatry Res. 2016;247:84-89.
    PubMed     Text format     Abstract available


  317. WADA A, Kunii Y, Matsumoto J, Hino M, et al
    Prominent increased calcineurin immunoreactivity in the superior temporal gyrus in schizophrenia: A postmortem study.
    Psychiatry Res. 2016;247:79-83.
    PubMed     Text format     Abstract available


  318. SAVILL M, Orfanos S, Bentall R, Reininghaus U, et al
    The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data.
    Psychiatry Res. 2016;247:73-78.
    PubMed     Text format     Abstract available


  319. XU F, Yu T, Niu W, Guo Z, et al
    Association study of NOS1 gene polymorphisms with the risk of schizophrenia in Chinese Han origin.
    Psychiatry Res. 2016 Nov 14. pii: S0165-1781(16)31274.
    PubMed     Text format    


  320. HUSA AP, Moilanen J, Murray GK, Marttila R, et al
    Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort.
    Psychiatry Res. 2016;247:130-138.
    PubMed     Text format     Abstract available


  321. KRAAN TC, Ising HK, Fokkema M, Velthorst E, et al
    The effect of childhood adversity on 4-year outcome in individuals at ultra high risk for psychosis in the Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
    Psychiatry Res. 2016;247:55-62.
    PubMed     Text format     Abstract available


  322. CORBERA S, Wexler BE, Poltorak A, Thime WR, et al
    Cognitive remediation for adults with schizophrenia: Does age matter?
    Psychiatry Res. 2016;247:21-27.
    PubMed     Text format     Abstract available


  323. ABDEL-BAKI A, Ouellet-Plamondon C, Salvat E, Grar K, et al
    Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis program.
    Psychiatry Res. 2016;247:113-119.
    PubMed     Text format     Abstract available


  324. ALI A, Carre A, Orri M, Urbach M, et al
    The real-life effectiveness of psychosocial therapies on social autonomy in schizophrenia patients: Results from a nationwide cohort study in France.
    Psychiatry Res. 2016;247:97-104.
    PubMed     Text format     Abstract available


  325. BAI Y, Wang W, Xu J, Zhang F, et al
    Altered resting-state regional homogeneity after 13 weeks of paliperidone injection treatment in schizophrenia patients.
    Psychiatry Res. 2016;258:37-43.
    PubMed     Text format     Abstract available


  326. XIAO W, Ye F, Ma L, Tang X, et al
    Atypical antipsychotic treatment increases glial cell line-derived neurotrophic factor serum levels in drug-free schizophrenic patients along with improvement of psychotic symptoms and therapeutic effects.
    Psychiatry Res. 2016 Nov 3. pii: S0165-1781(16)31176.
    PubMed     Text format     Abstract available


  327. LI H, Zhang Q, Li N, Wang F, et al
    Plasma levels of Th17-related cytokines and complement C3 correlated with aggressive behavior in patients with schizophrenia.
    Psychiatry Res. 2016 Nov 2. pii: S0165-1781(16)30841.
    PubMed     Text format     Abstract available


  328. WALTZMAN D, Knowlton BJ, Cohen JR, Bookheimer SY, et al
    DTI microstructural abnormalities in adolescent siblings of patients with childhood-onset schizophrenia.
    Psychiatry Res. 2016;258:23-29.
    PubMed     Text format    


  329. SUBRAMANIAPILLAI M, Tremblay L, Grassmann V, Remington G, et al
    The effect of an acute bout of exercise on executive function among individuals with schizophrenia.
    Psychiatry Res. 2016 Nov 1. pii: S0165-1781(16)30478.
    PubMed     Text format     Abstract available


  330. AKIYAMA K, Saito S, Saito A, Ozeki Y, et al
    Predictive value of premorbid IQ, negative symptoms, and age for cognitive and social functions in Japanese patients with schizophrenia: A study using the Japanese version of the Brief Assessment of Cognition in Schizophrenia.
    Psychiatry Res. 2016 Nov 1. pii: S0165-1781(16)30546.
    PubMed     Text format     Abstract available


  331. PRIKKEN M, van der Weiden A, Renes RA, Koevoets MG, et al
    Abnormal agency experiences in schizophrenia patients: Examining the role of psychotic symptoms and familial risk.
    Psychiatry Res. 2016;250:270-276.
    PubMed     Text format     Abstract available


    October 2016
  332. SHIN S, Yeom CW, Shin C, Shin JH, et al
    Activity monitoring using a mHealth device and correlations with psychopathology in patients with chronic schizophrenia.
    Psychiatry Res. 2016 Oct 31. pii: S0165-1781(16)30460.
    PubMed     Text format     Abstract available


  333. LEE SC, Tang SF, Lu WS, Huang SL, et al
    Minimal detectable change of the Personal and Social Performance scale in individuals with schizophrenia.
    Psychiatry Res. 2016 Oct 29. pii: S0165-1781(16)30072.
    PubMed     Text format     Abstract available


  334. GARDELLA R, Sacchetti E, Legati A, Magri C, et al
    Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia.
    Psychiatry Res. 2016 Oct 29. pii: S0165-1781(15)30866.
    PubMed     Text format    


  335. DEMILY C, Louchart-de-la-Chapelle S, Nkam I, Ramoz N, et al
    Does COMT val158met polymorphism influence P50 sensory gating, eye tracking or saccadic inhibition dysfunctions in schizophrenia?
    Psychiatry Res. 2016 Oct 27. pii: S0165-1781(16)30107.
    PubMed     Text format     Abstract available


  336. CAQUEO-URIZAR A, Alessandrini M, Zendjidjian X, Urzua A, et al
    Religion involvement and quality of life in caregivers of patients with schizophrenia in Latin-America.
    Psychiatry Res. 2016 Oct 27. pii: S0165-1781(16)30385.
    PubMed     Text format     Abstract available


  337. PILTON M, Bucci S, McManus J, Hayward M, et al
    Does insecure attachment mediate the relationship between trauma and voice-hearing in psychosis?
    Psychiatry Res. 2016 Oct 26. pii: S0165-1781(16)30038.
    PubMed     Text format     Abstract available


  338. YANG YJ, Xiong JW, Zhao Y, Zhan JQ, et al
    Increased plasma asymmetric dimethylarginine is associated with cognitive deficits in patients with schizophrenia.
    Psychiatry Res. 2016;246:480-484.
    PubMed     Text format     Abstract available


  339. SELLERS R, Gaweda L, Wells A, Morrison AP, et al
    The role of unhelpful metacognitive beliefs in psychosis: Relationships with positive symptoms and negative affect.
    Psychiatry Res. 2016;246:401-406.
    PubMed     Text format     Abstract available


  340. KINOSHITA M, Numata S, Tajima A, Nishi A, et al
    Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia risk.
    Psychiatry Res. 2016 Oct 17. pii: S0165-1781(16)30192.
    PubMed     Text format     Abstract available


  341. DOCX L, Emsell L, Van Hecke W, De Bondt T, et al
    White matter microstructure and volitional motor activity in schizophrenia: A diffusion kurtosis imaging study.
    Psychiatry Res. 2016;260:29-36.
    PubMed     Text format     Abstract available


    September 2016
  342. METZLER S, Dvorsky D, Wyss C, Nordt C, et al
    Neurocognition in help-seeking individuals at risk for psychosis: Prediction of outcome after 24 months.
    Psychiatry Res. 2016;246:188-194.
    PubMed     Text format     Abstract available


  343. WANG YX, Zhang P, Xin LM, Chen L, et al
    Chinese version of the Psychotropic-related Sexual Dysfunction Questionnaire (PRSexDQ -SALSEX): Validity and reliability for schizophrenic patients taking antipsychotics.
    Psychiatry Res. 2016;246:303-307.
    PubMed     Text format     Abstract available


  344. TANG XW, Yu M, Duan WW, Zhang XR, et al
    Facial emotion recognition and alexithymia in Chinese male patients with deficit schizophrenia.
    Psychiatry Res. 2016;246:353-359.
    PubMed     Text format     Abstract available


  345. PETRIKIS P, Boumba VA, Tzallas AT, Voulgari PV, et al
    Elevated levels of Insulin-like Growth Factor-1 (IGF-1) in drug-naive patients with psychosis.
    Psychiatry Res. 2016;246:348-352.
    PubMed     Text format     Abstract available


  346. PEREZ-BECERRIL C, Morris AG, Mortimer A, McKenna PJ, et al
    Common variants in the chromosome 2p23 region containing the SLC30A3 (ZnT3) gene are associated with schizophrenia in female but not male individuals in a large collection of European samples.
    Psychiatry Res. 2016;246:335-340.
    PubMed     Text format     Abstract available


  347. PARK HJ, Kim SK, Park JK, Kang WS, et al
    Association between coding single nucleotide polymorphisms in ADAMTS20 and schizophrenia in a Korean population.
    Psychiatry Res. 2016;246:332-334.
    PubMed     Text format    


  348. XI YB, Guo F, Li H, Chang X, et al
    The structural connectivity pathology of first-episode schizophrenia based on the cardinal symptom of auditory verbal hallucinations.
    Psychiatry Res. 2016;257:25-30.
    PubMed     Text format     Abstract available


  349. LAUFFS MM, Shaqiri A, Brand A, Roinishvili M, et al
    Local versus global and retinotopic versus non-retinotopic motion processing in schizophrenia patients.
    Psychiatry Res. 2016;246:461-465.
    PubMed     Text format     Abstract available


  350. COX C, Jolley S, Johns L
    Understanding and treating amotivation in people with psychosis: An experimental study of the role of guided imagery.
    Psychiatry Res. 2016;246:387-391.
    PubMed     Text format     Abstract available


  351. TREMEAU F, Antonius D, Malaspina D, Goff DC, et al
    Loneliness in schizophrenia and its possible correlates. An exploratory study.
    Psychiatry Res. 2016;246:211-217.
    PubMed     Text format     Abstract available


  352. CHEN S, Tian L, Chen N, Xiu M, et al
    Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.
    Psychiatry Res. 2016;247:6-11.
    PubMed     Text format     Abstract available


  353. GRILLAULT LAROCHE D, Gaillard A
    Induced Obsessive Compulsive Symptoms (OCS) in schizophrenia patients under Atypical 2 Antipsychotics (AAPs): review and hypotheses.
    Psychiatry Res. 2016;246:119-128.
    PubMed     Text format     Abstract available


  354. PAN S, Tan Y, Yao S, Zhao X, et al
    Serum high-sensitivity C-reactive protein: A delicate sentinel elevated in drug-free acutely agitated patients with schizophrenia.
    Psychiatry Res. 2016;246:89-94.
    PubMed     Text format     Abstract available


  355. FANG SH, Suzuki K, Lim CL, Chung MS, et al
    Associations between sleep quality and inflammatory markers in patients with schizophrenia.
    Psychiatry Res. 2016;246:154-160.
    PubMed     Text format     Abstract available


  356. MAZINANI R, Nejati S, Khodaei M
    Effects of memantine added to risperidone on the symptoms of schizophrenia: A randomized double-blind, placebo-controlled clinical trial.
    Psychiatry Res. 2016;247:291-295.
    PubMed     Text format     Abstract available


  357. HURTADO MM, Trivino M, Arnedo M, Roldan G, et al
    Are executive functions related to emotional intelligence? A correlational study in schizophrenia and borderline personality disorder.
    Psychiatry Res. 2016;246:84-88.
    PubMed     Text format     Abstract available


  358. SIDDI S, Petretto DR, Scanu R, Burrai C, et al
    Deficits in metaphor but not in idiomatic processing are related to verbal hallucinations in patients with psychosis.
    Psychiatry Res. 2016;246:101-112.
    PubMed     Text format     Abstract available


  359. ANDRIC S, Maric NP, Mihaljevic M, Mirjanic T, et al
    Familial covariation of facial emotion recognition and IQ in schizophrenia.
    Psychiatry Res. 2016;246:52-57.
    PubMed     Text format     Abstract available


  360. OLBERT CM, Penn DL, Reise SP, Horan WP, et al
    Assessment of attachment in psychosis: A psychometric cause for concern.
    Psychiatry Res. 2016;246:77-83.
    PubMed     Text format     Abstract available


  361. CHEN X, Duan M, He H, Yang M, et al
    Functional abnormalities of the right posterior insula are related to the altered self-experience in schizophrenia.
    Psychiatry Res. 2016;256:26-32.
    PubMed     Text format     Abstract available


  362. RODRIGUE AL, Austin BP, McDowell JE
    Plasticity of prefrontal cortex connectivity in schizophrenia in response to antisaccade practice.
    Psychiatry Res. 2016 Sep 12. pii: S0925-4927(16)30080.
    PubMed     Text format     Abstract available


  363. TALATI P, Rane S, Donahue MJ, Heckers S, et al
    Hippocampal arterial cerebral blood volume in early psychosis.
    Psychiatry Res. 2016;256:21-25.
    PubMed     Text format     Abstract available


  364. REED AC, Harris JG, Olincy A
    Schizophrenia, smoking status, and performance on the matrics Cognitive Consensus Battery.
    Psychiatry Res. 2016;246:1-8.
    PubMed     Text format     Abstract available


    August 2016
  365. VASCONCELOS E SA D, Wearden A, Hartley S, Emsley R, et al
    Expressed Emotion and behaviourally controlling interactions in the daily life of dyads experiencing psychosis.
    Psychiatry Res. 2016;245:406-413.
    PubMed     Text format     Abstract available


  366. YANG B, Niu W, Chen S, Xu F, et al
    Association study of dopamine receptor genes polymorphisms with the risk of schizophrenia in the Han Chinese population.
    Psychiatry Res. 2016;245:361-364.
    PubMed     Text format     Abstract available


  367. CHASE KA, Feiner B, Rosen C, Gavin DP, et al
    Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia.
    Psychiatry Res. 2016;245:346-353.
    PubMed     Text format     Abstract available


  368. ESSHILI A, Thabet S, Jemli A, Trifa F, et al
    Toxoplasma gondii infection in schizophrenia and associated clinical features.
    Psychiatry Res. 2016;245:327-332.
    PubMed     Text format     Abstract available


  369. ZHOU Y, Ning Y, Rosenheck R, Sun B, et al
    Effect of living with patients on caregiver burden of individual with schizophrenia in China.
    Psychiatry Res. 2016;245:230-237.
    PubMed     Text format     Abstract available


  370. KUMAR V, Rao NP, Narasimha V, Sathyanarayanan G, et al
    Antipsychotic dose in maintenance treatment of schizophrenia: A retrospective study.
    Psychiatry Res. 2016;245:311-316.
    PubMed     Text format     Abstract available


  371. ZHOU J, Xiang YT, Li Q, Zhu X, et al
    Gender differences in attitudes towards antipsychotic medications in patients with schizophrenia.
    Psychiatry Res. 2016;245:276-281.
    PubMed     Text format     Abstract available


  372. ALACAM H, Akgun S, Akca H, Ozturk O, et al
    miR-181b-5p, miR-195-5p and miR-301a-3p are related with treatment resistance in schizophrenia.
    Psychiatry Res. 2016;245:200-206.
    PubMed     Text format     Abstract available


  373. LUTHER L, Firmin RL, Minor KS, Vohs JL, et al
    Metacognition deficits as a risk factor for prospective motivation deficits in schizophrenia spectrum disorders.
    Psychiatry Res. 2016;245:172-178.
    PubMed     Text format     Abstract available


  374. BUTJOSA A, Gomez-Benito J, Huerta-Ramos E, Del Cacho N, et al
    Incidence of stressful life events and influence of sociodemographic and clinical variables on the onset of first-episode psychosis.
    Psychiatry Res. 2016;245:108-115.
    PubMed     Text format     Abstract available


  375. SUMIYOSHI C, Fujino H, Sumiyoshi T, Yasuda Y, et al
    Usefulness of the Wechsler Intelligence Scale short form for assessing functional outcomes in patients with schizophrenia.
    Psychiatry Res. 2016;245:371-378.
    PubMed     Text format     Abstract available


  376. MAUSBACH BT, Tiznado D, Cardenas V, Jeste DV, et al
    Validation of the UCSD Performance-based Skills Assessment (UPSA) in Hispanics with and without schizophrenia.
    Psychiatry Res. 2016;244:388-393.
    PubMed     Text format     Abstract available


  377. BURANEE K, Teeradej S, Chusak L, Michael M, et al
    Epilepsy-related psychoses and psychotic symptoms are significantly reduced by resective epilepsy surgery and are not associated with surgery outcome or epilepsy characteristics: A cohort study.
    Psychiatry Res. 2016;245:333-339.
    PubMed     Text format     Abstract available


  378. VANES LD, White TP, Wigton RL, Joyce D, et al
    Reduced susceptibility to the sound-induced flash fusion illusion in schizophrenia.
    Psychiatry Res. 2016;245:58-65.
    PubMed     Text format     Abstract available


  379. AYDIN O, Balikci K, Tas C, Aydin PU, et al
    The developmental origins of metacognitive deficits in schizophrenia.
    Psychiatry Res. 2016;245:15-21.
    PubMed     Text format     Abstract available


  380. BONFILS KA, Luther L, Firmin RL, Lysaker PH, et al
    Language and hope in schizophrenia-spectrum disorders.
    Psychiatry Res. 2016;245:8-14.
    PubMed     Text format     Abstract available


  381. SU CY, Wang PW, Lin YJ, Tang TC, et al
    The effects of aerobic exercise on cognition in schizophrenia: A 3-month follow-up study.
    Psychiatry Res. 2016;244:394-402.
    PubMed     Text format     Abstract available


  382. PANG B, Wang J, Zhang W, Gao Y, et al
    Increased histone deacetylase activity in peripheral blood mononuclear cells of patients with schizophrenia.
    Psychiatry Res. 2016;245:105-107.
    PubMed     Text format     Abstract available


  383. KARANIKAS E, Griveas I, Ntouros E, Floros G, et al
    Evidence for increased immune mobilization in First Episode Psychosis compared with the prodromal stage in males.
    Psychiatry Res. 2016;244:333-338.
    PubMed     Text format     Abstract available


    July 2016
  384. MINGRONE C, Montemagni C, Sandei L, Bava I, et al
    Coping strategies in schizoaffective disorder and schizophrenia: Differences and similarities.
    Psychiatry Res. 2016;244:317-323.
    PubMed     Text format     Abstract available


  385. VIZZOTTO AD, Celestino DL, Buchain PC, Oliveira AM, et al
    A pilot randomized controlled trial of the Occupational Goal Intervention method for the improvement of executive functioning in patients with treatment-resistant schizophrenia.
    Psychiatry Res. 2016;245:148-156.
    PubMed     Text format     Abstract available


  386. SUN ZL, Liu J, Guo W, Jiang T, et al
    Serum brain-derived neurotrophic factor levels associate with cognitive improvement in patients with schizophrenia treated with electroacupuncture.
    Psychiatry Res. 2016;244:370-375.
    PubMed     Text format     Abstract available


  387. TAKEUCHI H, Fervaha G, Remington G
    Reliability of a patient-reported outcome measure in schizophrenia: Results from back-to-back self-ratings.
    Psychiatry Res. 2016;244:415-419.
    PubMed     Text format     Abstract available


  388. EDWARDS CJ, Cella M, Tarrier N, Wykes T, et al
    The optimisation of experience sampling protocols in people with schizophrenia.
    Psychiatry Res. 2016;244:289-293.
    PubMed     Text format     Abstract available


  389. HU KF, Chou YH, Wen YH, Hsieh KP, et al
    Antipsychotic medications and dental caries in newly diagnosed schizophrenia: A nationwide cohort study.
    Psychiatry Res. 2016;245:45-50.
    PubMed     Text format     Abstract available


  390. CHEN XJ, Liu LL, Cui JF, Gan MY, et al
    The effect and mechanisms of implementation intention in improving prospective memory performance in schizophrenia patients.
    Psychiatry Res. 2016;244:86-93.
    PubMed     Text format     Abstract available


  391. CAO B, Wang DF, Xu MY, Liu YQ, et al
    Lower folate levels in schizophrenia: A meta-analysis.
    Psychiatry Res. 2016;245:1-7.
    PubMed     Text format     Abstract available


  392. RISPAUD SG, Rose J, Kurtz MM
    The relationship between change in cognition and change in functional ability in schizophrenia during cognitive and psychosocial rehabilitation.
    Psychiatry Res. 2016;244:145-150.
    PubMed     Text format     Abstract available


  393. ROOPRAM SM, Burger AM, van Dijk DA, Enterman J, et al
    A pilot study of bright light therapy in schizophrenia.
    Psychiatry Res. 2016;245:317-320.
    PubMed     Text format     Abstract available


  394. GARG S, Sinha VK, Tikka SK, Mishra P, et al
    The efficacy of cerebellar vermal deep high frequency (theta range) repetitive transcranial magnetic stimulation (rTMS) in schizophrenia: A randomized rater blind-sham controlled study.
    Psychiatry Res. 2016;243:413-420.
    PubMed     Text format     Abstract available


  395. DELICE M, Gurbuz O, Oflezer C, Kurt E, et al
    Palate size and shape in schizophrenia.
    Psychiatry Res. 2016;244:273-278.
    PubMed     Text format     Abstract available


  396. PILLNY M, Lincoln TM
    Predictors of improved functioning in patients with psychosis: The role of amotivation and defeatist performance beliefs.
    Psychiatry Res. 2016;244:117-122.
    PubMed     Text format     Abstract available


  397. TEIGSET CM, Mohn C, Rund BR
    Gestational length affects neurocognition in early-onset schizophrenia.
    Psychiatry Res. 2016;244:78-85.
    PubMed     Text format     Abstract available


  398. GREEN AE, Croft RJ, Maller JJ, Fitzgerald PB, et al
    White matter correlates of episodic memory encoding and retrieval in schizophrenia.
    Psychiatry Res. 2016;254:188-198.
    PubMed     Text format     Abstract available


  399. SANKARANARAYANAN A, Clark V, Baker A, Palazzi K, et al
    Reducing smoking reduces suicidality among individuals with psychosis: Complementary outcomes from a Healthy Lifestyles intervention study.
    Psychiatry Res. 2016;243:407-412.
    PubMed     Text format     Abstract available


  400. KOIVUKANGAS J, Bjornholm L, Tervonen O, Miettunen J, et al
    Body mass index and brain white matter structure in young adults at risk for psychosis - The Oulu Brain and Mind Study.
    Psychiatry Res. 2016;254:169-176.
    PubMed     Text format     Abstract available


  401. LIU L, Luo Y, Zhang G, Jin C, et al
    The mRNA expression of DRD2, PI3KCB, and AKT1 in the blood of acute schizophrenia patients.
    Psychiatry Res. 2016;243:397-402.
    PubMed     Text format     Abstract available


  402. YEE JY, See YM, Abdul Rashid NA, Neelamekam S, et al
    Association between serum levels of bioavailable vitamin D and negative symptoms in first-episode psychosis.
    Psychiatry Res. 2016;243:390-394.
    PubMed     Text format     Abstract available


  403. OHMURO N, Katsura M, Obara C, Kikuchi T, et al
    Deficits of cognitive theory of mind and its relationship with functioning in individuals with an at-risk mental state and first-episode psychosis.
    Psychiatry Res. 2016;243:318-325.
    PubMed     Text format     Abstract available


  404. LIU YW, Tzeng NS, Yeh CB, Kuo TB, et al
    Reduced cardiac autonomic response to deep breathing: A heritable vulnerability trait in patients with schizophrenia and their healthy first-degree relatives.
    Psychiatry Res. 2016;243:335-341.
    PubMed     Text format     Abstract available


  405. CHEN SD, Sun XY, Niu W, Kong LM, et al
    A preliminary analysis of microRNA-21 expression alteration after antipsychotic treatment in patients with schizophrenia.
    Psychiatry Res. 2016;244:324-332.
    PubMed     Text format     Abstract available


    June 2016
  406. IDRIZI R, Malcolm P, Weickert CS, Zavitsanou K, et al
    Striatal but not frontal cortical up-regulation of the epidermal growth factor receptor in rats exposed to immune activation in utero and cannabinoid treatment in adolescence.
    Psychiatry Res. 2016;240:260-4.
    PubMed     Text format     Abstract available


  407. XU Z, Mayer B, Muller M, Heekeren K, et al
    Stigma and suicidal ideation among young people at risk of psychosis after one year.
    Psychiatry Res. 2016;243:219-224.
    PubMed     Text format     Abstract available


  408. FONSECA-PEDRERO E, Gooding DC, Ortuno-Sierra J, Pflum M, et al
    Classifying risk status of non-clinical adolescents using psychometric indicators for psychosis spectrum disorders.
    Psychiatry Res. 2016;243:246-254.
    PubMed     Text format     Abstract available


  409. TOH WL, Castle DJ, Thomas N, Badcock JC, et al
    Auditory verbal hallucinations (AVHs) and related psychotic phenomena in mood disorders: analysis of the 2010 Survey of High Impact Psychosis (SHIP) data.
    Psychiatry Res. 2016;243:238-245.
    PubMed     Text format     Abstract available


  410. LIEBENBERG R, van Heerden B, Ehlers R, Du Plessis AM, et al
    Advancing paternal age at birth is associated with poorer social functioning earlier and later in life of schizophrenia patients in a founder population.
    Psychiatry Res. 2016;243:185-190.
    PubMed     Text format     Abstract available


  411. GROVE TB, Tso IF, Chun J, Mueller SA, et al
    Negative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated data analysis.
    Psychiatry Res. 2016;243:198-206.
    PubMed     Text format     Abstract available


  412. KAGEYAMA M, Solomon P, Kita S, Nagata S, et al
    Factors related to physical violence experienced by parents of persons with schizophrenia in Japan.
    Psychiatry Res. 2016;243:439-445.
    PubMed     Text format     Abstract available


  413. LEE JS, Kim ES, Kim EJ, Kim J, et al
    The relationship between self-referential processing-related brain activity and anhedonia in patients with schizophrenia.
    Psychiatry Res. 2016;254:112-118.
    PubMed     Text format     Abstract available


  414. MAO WC, Chen LF, Chi CH, Lin CH, et al
    Traditional Chinese version of the Mayer Salovey Caruso Emotional Intelligence Test (MSCEIT-TC): Its validation and application to schizophrenic individuals.
    Psychiatry Res. 2016;243:61-70.
    PubMed     Text format     Abstract available


  415. DEVRIM-UCOK M, Keskin-Ergen Y, Ucok A
    Lack of progressive reduction in P3 amplitude after the first-episode of schizophrenia: A 6-year follow-up study.
    Psychiatry Res. 2016;243:303-311.
    PubMed     Text format     Abstract available


  416. SCIOR K, Furnham A
    Causal beliefs about intellectual disability and schizophrenia and their relationship with awareness of the condition and social distance.
    Psychiatry Res. 2016;243:100-108.
    PubMed     Text format     Abstract available


  417. COBO J, Nieto L, Ochoa S, Pousa E, et al
    Insight and gender in schizophrenia and other psychoses.
    Psychiatry Res. 2016;243:268-277.
    PubMed     Text format     Abstract available


  418. HUANG TL, Lin CC, Chen RF, Lee CT, et al
    Higher blood MLL1 mRNA and BDNF promoter IV on histone H3K4me3 levels in patients with schizophrenia.
    Psychiatry Res. 2016;243:207-209.
    PubMed     Text format     Abstract available


  419. PAOLINI E, Moretti P, Compton MT
    Delusions in first-episode psychosis: Principal component analysis of twelve types of delusions and demographic and clinical correlates of resulting domains.
    Psychiatry Res. 2016;243:5-13.
    PubMed     Text format     Abstract available


  420. MACDOUGALL AG, Vandermeer MR, Norman RM
    Determinants of self-esteem in early psychosis: The role of perceived social dominance.
    Psychiatry Res. 2016 Jun 11. pii: S0165-1781(15)30270.
    PubMed     Text format     Abstract available


  421. DE ROSSI P, Dacquino C, Piras F, Caltagirone C, et al
    Left nucleus accumbens atrophy in deficit schizophrenia: A preliminary study.
    Psychiatry Res. 2016;254:48-55.
    PubMed     Text format     Abstract available


  422. ALLOZA C, Cox SR, Duff B, Semple SI, et al
    Information processing speed mediates the relationship between white matter and general intelligence in schizophrenia.
    Psychiatry Res. 2016;254:26-33.
    PubMed     Text format     Abstract available


  423. BUCHY L, Mathalon DH, Cannon TD, Cadenhead KS, et al
    Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis.
    Psychiatry Res. 2016;254:3-9.
    PubMed     Text format     Abstract available


  424. CHANG WC, Lau CF, Chan SS, Hui CL, et al
    Premorbid, clinical and cognitive correlates of primary negative symptoms in first-episode psychosis.
    Psychiatry Res. 2016;242:144-149.
    PubMed     Text format     Abstract available


  425. FERVAHA G, Agid O, Takeuchi H, Foussias G, et al
    Life satisfaction and happiness among young adults with schizophrenia.
    Psychiatry Res. 2016;242:174-179.
    PubMed     Text format     Abstract available


    May 2016
  426. BROWNE J, Penn DL, Raykov T, Pinkham AE, et al
    Social cognition in schizophrenia: Factor structure of emotion processing and theory of mind.
    Psychiatry Res. 2016;242:150-156.
    PubMed     Text format     Abstract available


  427. UNDERWOOD R, Kumari V, Peters E
    Cognitive and neural models of threat appraisal in psychosis: A theoretical integration.
    Psychiatry Res. 2016;239:131-8.
    PubMed     Text format     Abstract available


  428. KASCKOW J, Zickmund S, Gurklis J, Luther J, et al
    Using telehealth to augment an intensive case monitoring program in veterans with schizophrenia and suicidal ideation: A pilot trial.
    Psychiatry Res. 2016;239:111-6.
    PubMed     Text format     Abstract available


  429. PEITL V, Vidrih B, Karlovic Z, Getaldic B, et al
    Platelet serotonin concentration and depressive symptoms in patients with schizophrenia.
    Psychiatry Res. 2016;239:105-10.
    PubMed     Text format     Abstract available


  430. CAVELTI M, Homan P, Vauth R
    The impact of thought disorder on therapeutic alliance and personal recovery in schizophrenia and schizoaffective disorder: An exploratory study.
    Psychiatry Res. 2016;239:92-8.
    PubMed     Text format     Abstract available


  431. RAKITZI S, Georgila P, Efthimiou K, Mueller DR, et al
    Efficacy and feasibility of the Integrated Psychological Therapy for outpatients with schizophrenia in Greece: Final results of a RCT.
    Psychiatry Res. 2016;242:137-143.
    PubMed     Text format     Abstract available


  432. VERGARA-MORAGUES E, Mestre-Pinto JI, Gomez PA, Rodriguez-Fonseca F, et al
    Can symptoms help in differential diagnosis between substance-induced vs independent psychosis in adults with a lifetime diagnosis of cocaine use disorder?
    Psychiatry Res. 2016;242:94-100.
    PubMed     Text format     Abstract available


  433. MENDES-FILHO VA, de Jesus DR, Belmonte-de-Abreu P, Cachoeira CT, et al
    Effects of repetitive transcranial magnetic stimulation over supplementary motor area in patients with schizophrenia with obsessive-compulsive-symptoms: A pilot study.
    Psychiatry Res. 2016;242:34-38.
    PubMed     Text format     Abstract available


  434. BERRADA-BABY Z, Oker A, Courgeon M, Urbach M, et al
    Patients with schizophrenia are less prone to interpret virtual others' empathetic questioning as helpful.
    Psychiatry Res. 2016;242:67-74.
    PubMed     Text format     Abstract available


  435. STRZELECKI D, Kaluzynska O, Wysokinski A
    BDNF serum levels in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).
    Psychiatry Res. 2016;242:54-60.
    PubMed     Text format     Abstract available


  436. OLSSON AK, Hjarthag F, Helldin L
    Predicting real-world functional milestones in schizophrenia.
    Psychiatry Res. 2016;242:1-6.
    PubMed     Text format     Abstract available


  437. SHAIKH M, Ellett L, Dutt A, Day F, et al
    Perceived ethnic discrimination and persecutory paranoia in individuals at ultra-high risk for psychosis.
    Psychiatry Res. 2016;241:309-314.
    PubMed     Text format     Abstract available


  438. BUOLI M, Bertino V, Caldiroli A, Dobrea C, et al
    Are obstetrical complications really involved in the etiology and course of schizophrenia and mood disorders?
    Psychiatry Res. 2016;241:297-301.
    PubMed     Text format     Abstract available


  439. WU L, Chen F, Wei J, Shen Y, et al
    Study of the tetraspanin 18 association with schizophrenia in a Han Chinese population.
    Psychiatry Res. 2016;241:263-266.
    PubMed     Text format     Abstract available


  440. BUCHTEMANN D, Kastner D, Warnke I, Radisch J, et al
    Hospital utilization outcome of an assertive outreach model for schizophrenic patients - results of a quasi-experimental study.
    Psychiatry Res. 2016;241:249-255.
    PubMed     Text format     Abstract available


  441. FERNANDEZ G, Guinjoan S, Sapognikoff M, Orozco D, et al
    Contextual predictability enhances reading performance in patients with schizophrenia.
    Psychiatry Res. 2016;241:333-339.
    PubMed     Text format     Abstract available


  442. KIMURA H, Kanahara N, Takase M, Yoshida T, et al
    A randomized, sham-controlled study of high frequency rTMS for auditory hallucination in schizophrenia.
    Psychiatry Res. 2016;241:190-194.
    PubMed     Text format     Abstract available


  443. SINGH A, Mattoo SK, Grover S
    Stigma and its correlates among caregivers of schizophrenia: A study from North India.
    Psychiatry Res. 2016;241:302-308.
    PubMed     Text format     Abstract available


  444. SEVOS J, Grosselin A, Fedotova T, Massoubre C, et al
    Behavioral predispositions to approach or avoid emotional words in schizophrenia.
    Psychiatry Res. 2016;241:195-200.
    PubMed     Text format     Abstract available


  445. ONG HL, Subramaniam M, Abdin E, Wang P, et al
    Performance of Mini-Mental State Examination (MMSE) in long-stay patients with schizophrenia or schizoaffective disorders in a psychiatric institute.
    Psychiatry Res. 2016;241:256-262.
    PubMed     Text format     Abstract available


  446. GRAU N, Rubio-Abadal E, Usall J, Barajas A, et al
    Influence of cognition, premorbid adjustment and psychotic symptoms on psycho-social functioning in first-episode psychosis.
    Psychiatry Res. 2016;242:157-162.
    PubMed     Text format     Abstract available


    April 2016
  447. HOLLANDER S, Hochman E, Shoval G, Taler M, et al
    The association between serum creatine kinase, mood and psychosis in inpatients with schizophrenia, bipolar and schizoaffective disorders.
    Psychiatry Res. 2016;238:333-7.
    PubMed     Text format     Abstract available


  448. LEDDY-STACY MA, Rosenheck R
    Obtaining employment as an anchor for estimating the minimum clinically important difference on the Positive and Negative Syndrome Scale (PANSS) in schizophrenia.
    Psychiatry Res. 2016;238:304-9.
    PubMed     Text format     Abstract available


  449. MADEIRA L, Bonoldi I, Rocchetti M, Brandizzi M, et al
    Prevalence and implications of Truman symptoms in subjects at ultra high risk for psychosis.
    Psychiatry Res. 2016;238:270-6.
    PubMed     Text format     Abstract available


  450. SMITH EA, Bolinskey PK, Guidi JP, Myers KR, et al
    Further examination of the factor structure of the Chapman Psychosis Proneness Scales (CPPS).
    Psychiatry Res. 2016;238:257-63.
    PubMed     Text format     Abstract available


  451. EISENACHER S, Rausch F, Mier D, Fenske S, et al
    Bias against disconfirmatory evidence in the 'at-risk mental state' and during psychosis.
    Psychiatry Res. 2016;238:242-50.
    PubMed     Text format     Abstract available


  452. KALISZ A, Cechnicki A
    The stability of negative syndrome, persistent negative syndrome and deficit syndrome in a twenty-year follow-up study of schizophrenia patients.
    Psychiatry Res. 2016;238:236-41.
    PubMed     Text format     Abstract available


  453. SCHOLTE-STALENHOEF AN, la Bastide-van Gemert S, van de Willige G, Dost-Otter R, et al
    Personality and coping in first episode psychosis linked to mental health care use.
    Psychiatry Res. 2016;238:218-24.
    PubMed     Text format     Abstract available


  454. NONAKA-HASHIDA S, Sekine M, Ozeki Y, Fujii K, et al
    Plasma concentrations of three methylated arginines, endogenous nitric oxide synthase inhibitors, in schizophrenic patients undergoing antipsychotic drug treatment.
    Psychiatry Res. 2016;238:203-10.
    PubMed     Text format     Abstract available


  455. WU JQ, Chen da C, Tan YL, Xiu MH, et al
    Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.
    Psychiatry Res. 2016;238:196-202.
    PubMed     Text format     Abstract available


  456. MARCO C, Antonio D, Antonina S, Alessandro S, et al
    Corrigendum to "Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by schizophrenia and bipolar disorder and controls" [Psychiatry Res. 228 (2015) 945-949].
    Psychiatry Res. 2016;238:165.
    PubMed     Text format    


  457. TREMEAU F, Antonius D, Todorov A, Rebani Y, et al
    What can the study of first impressions tell us about attitudinal ambivalence and paranoia in schizophrenia?
    Psychiatry Res. 2016;238:86-92.
    PubMed     Text format     Abstract available


  458. MISIAK B, Laczmanski L, Sloka NK, Szmida E, et al
    Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism.
    Psychiatry Res. 2016;238:60-7.
    PubMed     Text format     Abstract available


  459. PARK IJ, Jung DC, Hwang SS, Jung HY, et al
    The longitudinal trends in the relationship between drug-induced extrapyramidal symptoms and personal and social performance in a population of the patients with schizophrenia: A latent growth model.
    Psychiatry Res. 2016;238:33-9.
    PubMed     Text format     Abstract available


  460. PALMIER-CLAUS J, Berry K, Darrell-Berry H, Emsley R, et al
    Childhood adversity and social functioning in psychosis: Exploring clinical and cognitive mediators.
    Psychiatry Res. 2016;238:25-32.
    PubMed     Text format     Abstract available


  461. TRAUELSEN AM, Gumley A, Jansen JE, Pedersen MB, et al
    Metacognition in first-episode psychosis and its association with positive and negative symptom profiles.
    Psychiatry Res. 2016;238:14-23.
    PubMed     Text format     Abstract available


  462. NORDHOLM D, Poulsen HE, Hjorthoj C, Randers L, et al
    Systemic oxidative DNA and RNA damage are not increased during early phases of psychosis: A case control study.
    Psychiatry Res. 2016;241:201-206.
    PubMed     Text format     Abstract available


  463. DAVIDSON CA, Hoffman L, Spaulding WD
    Schizotypal personality questionnaire--brief revised (updated): An update of norms, factor structure, and item content in a large non-clinical young adult sample.
    Psychiatry Res. 2016;238:345-55.
    PubMed     Text format     Abstract available


  464. RASMUSSEN SA, Rosebush PI, Anglin RE, Mazurek MF, et al
    The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine.
    Psychiatry Res. 2016;241:72-77.
    PubMed     Text format     Abstract available


  465. JIN C, Zhou Z, Li W, Zhang F, et al
    Analysis of the association of VIPR2 polymorphisms with susceptibility to schizophrenia.
    Psychiatry Res. 2016;241:104-107.
    PubMed     Text format     Abstract available


  466. GONZALEZ-LIENCRES C, Brown EC, Tas C, Breidenstein A, et al
    Alterations in event-related potential responses to empathy for pain in schizophrenia.
    Psychiatry Res. 2016;241:14-21.
    PubMed     Text format     Abstract available


  467. KORKMAZ S, Korkmaz H, Ozer O, Atmaca M, et al
    Assessment of left ventricle systolic and diastolic functions in schizophrenia patients.
    Psychiatry Res. 2016;240:348-351.
    PubMed     Text format     Abstract available


  468. BULZACKA E, Delourme G, Hutin V, Burban N, et al
    Clinical utility of the Multiple Errands Test in schizophrenia: A preliminary assessment.
    Psychiatry Res. 2016;240:390-397.
    PubMed     Text format     Abstract available


  469. WILLI TS, Honer WG, Thornton AE, Gicas K, et al
    Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence.
    Psychiatry Res. 2016;240:336-342.
    PubMed     Text format     Abstract available


  470. LI Z, Yin M, Lyu XL, Zhang LL, et al
    Delayed effect of repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia: Findings from a randomized controlled trial.
    Psychiatry Res. 2016;240:333-335.
    PubMed     Text format     Abstract available


  471. TELO S, Gurok MG
    Asymmetric dimethylarginine (ADMA), 4-OH-nonenal and Vitamin E levels in chronic schizophrenic patients.
    Psychiatry Res. 2016;240:295-299.
    PubMed     Text format    


  472. JHA S, Garg A
    Add on testosterone therapy in negative symptoms of schizophrenia with gonadal trauma: Hitting the bull's eye.
    Psychiatry Res. 2016;240:265-266.
    PubMed     Text format     Abstract available


  473. FARNIA V, Shakeri J, Tatari F, Juibari TA, et al
    Demographic and mental history-related data predicted occurrence of psychosis in metamphetamine users.
    Psychiatry Res. 2016;240:431-434.
    PubMed     Text format     Abstract available


  474. BAANDRUP L, Glenthoj BY, Jennum PJ
    Objective and subjective sleep quality: Melatonin versus placebo add-on treatment in patients with schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use.
    Psychiatry Res. 2016;240:163-169.
    PubMed     Text format     Abstract available


  475. MAO Q, Tan YL, Luo XG, Tian L, et al
    Association of catechol-O-methyltransferase Val108/158 Met genetic polymorphism with schizophrenia, P50 sensory gating, and negative symptoms in a Chinese population.
    Psychiatry Res. 2016;242:271-276.
    PubMed     Text format     Abstract available


  476. MORRISON AP, Burke E, Murphy E, Pyle M, et al
    Cognitive therapy for internalised stigma in people experiencing psychosis: A pilot randomised controlled trial.
    Psychiatry Res. 2016;240:96-102.
    PubMed     Text format     Abstract available


  477. JOYAL M, Bonneau A, Fecteau S
    Speech and language therapies to improve pragmatics and discourse skills in patients with schizophrenia.
    Psychiatry Res. 2016;240:88-95.
    PubMed     Text format     Abstract available


  478. KOUTRA K, Simos P, Triliva S, Lionis C, et al
    Linking family cohesion and flexibility with expressed emotion, family burden and psychological distress in caregivers of patients with psychosis: A path analytic model.
    Psychiatry Res. 2016;240:66-75.
    PubMed     Text format     Abstract available


  479. FEINGOLD D, Hasson-Ohayon I, Laukka P, Vishne T, et al
    Emotion recognition deficits among persons with schizophrenia: Beyond stimulus complexity level and presentation modality.
    Psychiatry Res. 2016;240:60-65.
    PubMed     Text format     Abstract available


  480. OHI K, Shimada T, Nitta Y, Kihara H, et al
    The Five-Factor Model personality traits in schizophrenia: A meta-analysis.
    Psychiatry Res. 2016;240:34-41.
    PubMed     Text format     Abstract available


  481. CHARAN A, Shewade DG, Rajkumar RP, Chandrasekaran A, et al
    Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia.
    Psychiatry Res. 2016;240:209-213.
    PubMed     Text format     Abstract available


  482. VOGEL B, Bruck C, Jacob H, Eberle M, et al
    Integration of verbal and nonverbal emotional signals in patients with schizophrenia: Decreased nonverbal dominance.
    Psychiatry Res. 2016;241:98-103.
    PubMed     Text format     Abstract available


    March 2016
  483. JIN C, Zhang X, Liu X, Li W, et al
    Association study of KIBRA rs17070145 polymorphism with the risk of schizophrenia in the Han Chinese population.
    Psychiatry Res. 2016;239:331-332.
    PubMed     Text format    


  484. HUDDY V, Drake G, Wykes T
    Mental simulation and experience as determinants of performance expectancies in people with schizophrenia spectrum disorder.
    Psychiatry Res. 2016;237:97-102.
    PubMed     Text format     Abstract available


  485. GOMES E, Bastos T, Probst M, Ribeiro JC, et al
    Reliability and validity of 6MWT for outpatients with schizophrenia: A preliminary study.
    Psychiatry Res. 2016;237:37-42.
    PubMed     Text format     Abstract available


  486. BATTY RA, Francis A, Thomas N, Hopwood M, et al
    A brief neurocognitive assessment of patients with psychosis following traumatic brain injury (PFTBI): Use of the Repeatable battery for the Assessment of Neuropsychological Status (RBANS).
    Psychiatry Res. 2016;237:27-36.
    PubMed     Text format     Abstract available


  487. GRANO N, Karjalainen M, Ranta K, Lindgren M, et al
    Community-oriented family-based intervention superior to standard treatment in improving depression, hopelessness and functioning among adolescents with any psychosis-risk symptoms.
    Psychiatry Res. 2016;237:9-16.
    PubMed     Text format     Abstract available


  488. FAGET-AGIUS C, Boyer L, Richieri R, Auquier P, et al
    Functional brain substrate of quality of life in patients with schizophrenia: A brain SPECT multidimensional analysis.
    Psychiatry Res. 2016;249:67-75.
    PubMed     Text format     Abstract available


  489. ZHENG J, Zhang Y, Guo X, Duan X, et al
    Disrupted amplitude of low-frequency fluctuations in antipsychotic-naive adolescents with early-onset schizophrenia.
    Psychiatry Res. 2016;249:20-6.
    PubMed     Text format     Abstract available


  490. KIM EY, Kim SH, Lee HJ, Kim B, et al
    Sex-specific association between the albumin D-element binding protein gene and metabolic syndrome in patients with bipolar disorder and schizophrenia.
    Psychiatry Res. 2016;240:47-52.
    PubMed     Text format    


  491. QIAO Y, Yang F, Li C, Guo Q, et al
    Add-on effects of a low-dose aripiprazole in resolving hyperprolactinemia induced by risperidone or paliperidone.
    Psychiatry Res. 2016;237:83-9.
    PubMed     Text format     Abstract available


  492. MARQUEZ-ARRICO JE, Lopez-Vera S, Prat G, Adan A, et al
    Temperament and character dimensions in male patients with substance use disorders: Differences relating to psychiatric comorbidity.
    Psychiatry Res. 2016;237:1-8.
    PubMed     Text format     Abstract available


  493. LANGSRUD K, Vaaler AE, Kallestad H, Morken G, et al
    Sleep patterns as a predictor for length of stay in a psychiatric intensive care unit.
    Psychiatry Res. 2016;237:252-6.
    PubMed     Text format     Abstract available


  494. CARRA G, Johnson S, Crocamo C, Angermeyer MC, et al
    Psychosocial functioning, quality of life and clinical correlates of comorbid alcohol and drug dependence syndromes in people with schizophrenia across Europe.
    Psychiatry Res. 2016;239:301-307.
    PubMed     Text format     Abstract available


  495. BERNARDINI F, Lunden A, Covington M, Broussard B, et al
    Associations of acoustically measured tongue/jaw movements and portion of time speaking with negative symptom severity in patients with schizophrenia in Italy and the United States.
    Psychiatry Res. 2016;239:253-258.
    PubMed     Text format     Abstract available


  496. SHI J, Wang L, Yao Y, Chen F, et al
    Protective factors in Chinese university students at clinical high risk for psychosis.
    Psychiatry Res. 2016;239:239-244.
    PubMed     Text format     Abstract available


  497. LANG FU, Muller-Stierlin AS, Walther S, Stegmayer K, et al
    Dimensional approaches to schizophrenia: A comparison of the Bern Psychopathology scale and the five-factor model of the Positive and Negative Syndrome Scale.
    Psychiatry Res. 2016;239:284-290.
    PubMed     Text format     Abstract available


  498. TAKAHASHI T, Nakamura M, Nishikawa Y, Takayanagi Y, et al
    Decreased number of orbital sulci in schizophrenia spectrum disorders.
    Psychiatry Res. 2016;250:29-32.
    PubMed     Text format     Abstract available


  499. ONIKI K, Kamihashi R, Tomita T, Ishioka M, et al
    Glutathione S-transferase K1 genotype and overweight status in schizophrenia patients: A pilot study.
    Psychiatry Res. 2016;239:190-195.
    PubMed     Text format     Abstract available


  500. ALAMEDA L, Golay P, Baumann P, Morandi S, et al
    Assertive outreach for "difficult to engage" patients: A useful tool for a subgroup of patients in specialized early psychosis intervention programs.
    Psychiatry Res. 2016;239:212-219.
    PubMed     Text format     Abstract available


    February 2016
  501. KOSTEN L, Verhaeghe J, Verkerk R, Thomae D, et al
    Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunction.
    Psychiatry Res. 2016;248:1-11.
    PubMed     Text format     Abstract available


  502. LAKO IM, Taxis K, van den Heuvel ER, Leenaars CH, et al
    Altered emotional experiences attributed to antipsychotic medications - A potential link with estimated dopamine D2 receptor occupancy.
    Psychiatry Res. 2016;236:9-14.
    PubMed     Text format     Abstract available


  503. RICH AM, Cho YT, Tang Y, Savic A, et al
    Amygdala volume is reduced in early course schizophrenia.
    Psychiatry Res. 2016;250:50-60.
    PubMed     Text format     Abstract available


    January 2016
  504. VAN DONGEN JD, Buck NM, van Marle HJ
    Positive symptoms, substance use, and psychopathic traits as predictors of aggression in persons with a schizophrenia disorder.
    Psychiatry Res. 2016 Jan 28. pii: S0165-1781(16)30156.
    PubMed     Text format     Abstract available


  505. DUNCAN MJ, Faulkner G, Remington G, Arbour-Nicitopoulos K, et al
    Characterizing the affective responses to an acute bout of moderate-intensity exercise among outpatients with schizophrenia.
    Psychiatry Res. 2016 Jan 28. pii: S0165-1781(16)30081.
    PubMed     Text format     Abstract available


  506. MINICHINO A, Singh F, Pineda J, Friederich E, et al
    Biological Motion induced mu suppression is reduced in Early Psychosis (EP) patients with active negative symptoms and Autism Spectrum Disorders (ASD).
    Psychiatry Res. 2016 Jan 26. pii: S0165-1781(16)30145.
    PubMed     Text format     Abstract available


  507. ZHANG Q, Li X, Parker GJ, Hong XH, et al
    Theory of mind correlates with clinical insight but not cognitive insight in patients with schizophrenia.
    Psychiatry Res. 2016 Jan 22. pii: S0165-1781(16)30118.
    PubMed     Text format     Abstract available


  508. WYSOKINSKI A, Szczepocka E
    Platelet parameters (PLT, MPV, P-LCR) in patients with schizophrenia, unipolar depression and bipolar disorder.
    Psychiatry Res. 2016 Jan 16. pii: S0165-1781(16)30085.
    PubMed     Text format     Abstract available


  509. HAJNAL A, Csabi G, Herold R, Jeges S, et al
    Minor physical anomalies are more common among the first-degree unaffected relatives of schizophrenia patients - Results with the Mehes Scale.
    Psychiatry Res. 2016 Jan 16. pii: S0165-1781(16)30090.
    PubMed     Text format     Abstract available


  510. MAKOWSKI AC, Mnich EE, Ludwig J, Daubmann A, et al
    Changes in beliefs and attitudes toward people with depression and schizophrenia - results of a public campaign in Germany.
    Psychiatry Res. 2016 Jan 15. pii: S0165-1781(16)30071.
    PubMed     Text format     Abstract available


  511. CHOUINARD VA, Pingali SM, Chouinard G, Henderson DC, et al
    Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders.
    Psychiatry Res. 2016 Jan 14. pii: S0165-1781(16)30062.
    PubMed     Text format     Abstract available


  512. OZEKI Y, Sekine M, Fujii K, Watanabe T, et al
    Phosphoserine phosphatase activity is elevated and correlates negatively with plasma d-serine concentration in patients with schizophrenia.
    Psychiatry Res. 2016 Jan 12. pii: S0165-1781(16)30018.
    PubMed     Text format     Abstract available


  513. WU BJ, Liao HY, Chen HK, Lan TH, et al
    Psychopathology, psychopharmacological properties, decision-making capacity to consent to clinical research and the willingness to participate among long-term hospitalized patients with schizophrenia.
    Psychiatry Res. 2016 Jan 12. pii: S0165-1781(16)30046.
    PubMed     Text format     Abstract available


  514. GENC A, Kalelioglu T, Karamustafalioglu N, Tasdemir A, et al
    Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia.
    Psychiatry Res. 2016 Jan 9. pii: S0165-1781(15)30106.
    PubMed     Text format     Abstract available


  515. THOMPSON A, Marwaha S, Nelson B, Wood SJ, et al
    Do affective or dissociative symptoms mediate the association between childhood sexual trauma and transition to psychosis in an ultra-high risk cohort?
    Psychiatry Res. 2016 Jan 8. pii: S0165-1781(15)30410.
    PubMed     Text format     Abstract available


  516. CAQUEO-URIZAR A, Urzua A, Jamett PR, Irarrazaval M, et al
    Objective and subjective burden in relatives of patients with schizophrenia and its influence on care relationships in Chile.
    Psychiatry Res. 2016 Jan 8. pii: S0165-1781(16)30024.
    PubMed     Text format     Abstract available


  517. TANG DY, Liu AC, Lui SS, Lam BY, et al
    Facial emotion perception impairments in schizophrenia patients with comorbid antisocial personality disorder.
    Psychiatry Res. 2016 Jan 6. pii: S0165-1781(15)30153.
    PubMed     Text format     Abstract available


  518. KAMP D, Brinkmeyer J, Agelink MW, Habakuck M, et al
    High frequency repetitive transcranial magnetic stimulation (rTMS) reduces EEG-hypofrontality in patients with schizophrenia.
    Psychiatry Res. 2016 Jan 6. pii: S0165-1781(16)30011.
    PubMed     Text format     Abstract available


  519. GONZALEZ-GIRALDO Y, Gonzalez-Reyes RE, Forero DA
    A functional variant in MIR137, a candidate gene for schizophrenia, affects Stroop test performance in young adults.
    Psychiatry Res. 2016 Jan 5. pii: S0165-1781(15)30349.
    PubMed     Text format     Abstract available


  520. AHMED AO, Murphy CF, Latoussakis V, McGovern KE, et al
    An examination of neurocognition and symptoms as predictors of post-hospital community tenure in treatment resistant schizophrenia.
    Psychiatry Res. 2016 Jan 5. pii: S0165-1781(15)30030.
    PubMed     Text format     Abstract available


  521. UHLMANN A, Fouche JP, Koen N, Meintjes EM, et al
    Fronto-temporal alterations and affect regulation in methamphetamine dependence with and without a history of psychosis.
    Psychiatry Res. 2016 Jan 4. pii: S0925-4927(16)30002.
    PubMed     Text format     Abstract available


  522. ARNOLD AE, Iaria G, Goghari VM
    Efficacy of identifying neural components in the face and emotion processing system in schizophrenia using a dynamic functional localizer.
    Psychiatry Res. 2016 Jan 4. pii: S0925-4927(16)30003.
    PubMed     Text format     Abstract available


  523. WOODWARD TS, Leong K, Sanford N, Tipper CM, et al
    Altered balance of functional brain networks in Schizophrenia.
    Psychiatry Res. 2016 Jan 4. pii: S0925-4927(16)30004.
    PubMed     Text format     Abstract available


  524. LEE SJ, Kim B, Oh D, Kim MK, et al
    White matter alterations associated with suicide in patients with schizophrenia or schizophreniform disorder.
    Psychiatry Res. 2016 Jan 4. pii: S0925-4927(16)30009.
    PubMed     Text format     Abstract available


    December 2015
  525. TAKAESU Y, Kishimoto T, Murakoshi A, Takahashi N, et al
    Factors associated with discontinuation of aripiprazole treatment after switching from other antipsychotics in patients with chronic schizophrenia: A prospective observational study.
    Psychiatry Res. 2015 Dec 23. pii: S0165-1781(15)30870.
    PubMed     Text format     Abstract available


  526. RENES RA, Vink M, van der Weiden A, Prikken M, et al
    Impaired frontal processing during agency inferences in schizophrenia.
    Psychiatry Res. 2015 Dec 23. pii: S0925-4927(15)30186.
    PubMed     Text format     Abstract available


  527. MANCHIA M, Pinna M, Carpiniello B
    Haloperidol and loss of gray matter in schizophrenia: Reconciling meta-analytical results with molecular pharmacology.
    Psychiatry Res. 2015 Dec 19. pii: S0165-1781(15)30345.
    PubMed     Text format    


  528. FINEBERG AM, Ellman LM, Schaefer CA, Maxwell SD, et al
    Fetal exposure to maternal stress and risk for schizophrenia spectrum disorders among offspring: Differential influences of fetal sex.
    Psychiatry Res. 2015 Dec 18. pii: S0165-1781(15)30836.
    PubMed     Text format     Abstract available


  529. WATANABE Y, Nunokawa A, Shibuya M, Ikeda M, et al
    Rare truncating variations and risk of schizophrenia: Whole-exome sequencing in three families with affected siblings and a three-stage follow-up study in a Japanese population.
    Psychiatry Res. 2015 Dec 11. pii: S0165-1781(15)30452.
    PubMed     Text format     Abstract available


  530. ROCHE E, Segurado R, Renwick L, McClenaghan A, et al
    Language disturbance and functioning in first episode psychosis.
    Psychiatry Res. 2015 Dec 9. pii: S0165-1781(15)30799.
    PubMed     Text format     Abstract available


  531. WATSON A, Pribadi M, Chowdari K, Clifton S, et al
    C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis.
    Psychiatry Res. 2015 Dec 8. pii: S0165-1781(15)30794.
    PubMed     Text format     Abstract available


  532. CAO XL, Li Y, Zhong BL, Chiu HF, et al
    Current cigarette smoking in Chinese female patients with schizophrenia: A meta-analysis.
    Psychiatry Res. 2015 Dec 3. pii: S0165-1781(15)30113.
    PubMed     Text format     Abstract available


  533. AGARWAL SM, Bose A, Shivakumar V, Narayanaswamy JC, et al
    Impact of antipsychotic medication on transcranial direct current stimulation (tDCS) effects in schizophrenia patients.
    Psychiatry Res. 2015 Dec 2. pii: S0165-1781(15)30087.
    PubMed     Text format     Abstract available


    November 2015
  534. NITKA F, Richter J, Parzer P, Resch F, et al
    Health-related quality of life among adolescents: A comparison between subjects at ultra-high risk for psychosis and healthy controls.
    Psychiatry Res. 2015 Nov 30. pii: S0165-1781(15)30135.
    PubMed     Text format     Abstract available


  535. CHEN LF, Liu J, Zhang J, Lu XQ, et al
    Non-pharmacological interventions for caregivers of patients with schizophrenia: A meta-analysis.
    Psychiatry Res. 2015 Nov 27. pii: S0165-1781(15)30707.
    PubMed     Text format     Abstract available


  536. SIEGRIST K, Millier A, Amri I, Aballea S, et al
    Association between social contact frequency and negative symptoms, psychosocial functioning and quality of life in patients with schizophrenia.
    Psychiatry Res. 2015 Nov 25. pii: S0165-1781(15)30713.
    PubMed     Text format     Abstract available


  537. BUCHY L, Seidman LJ, Cadenhead KS, Cannon TD, et al
    Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis.
    Psychiatry Res. 2015 Nov 25. pii: S0165-1781(15)30166.
    PubMed     Text format     Abstract available


  538. WANG D, Zhai JX, Liu DW
    Serum folate levels in schizophrenia: A meta-analysis.
    Psychiatry Res. 2015 Nov 25. pii: S0165-1781(15)30731.
    PubMed     Text format     Abstract available


  539. NUNEZ C, Stephan-Otto C, Cuevas-Esteban J, Maria Haro J, et al
    Effects of caffeine intake and smoking on neurocognition in schizophrenia.
    Psychiatry Res. 2015 Nov 21. pii: S0165-1781(15)30679.
    PubMed     Text format     Abstract available


  540. WANG J, Wang P, Xia Z, Liu J, et al
    Lexical and sub-lexical reading skills and their correlation to clinical symptoms in young Chinese patients with schizophrenia.
    Psychiatry Res. 2015 Nov 20. pii: S0165-1781(15)30677.
    PubMed     Text format     Abstract available


  541. MALCOLM CP, Picchioni MM, Ellett L
    Intrusive prospective imagery, posttraumatic intrusions and anxiety in schizophrenia.
    Psychiatry Res. 2015 Nov 19. pii: S0165-1781(15)30696.
    PubMed     Text format     Abstract available


  542. SCHULZE-RAUSCHENBACH S, Lennertz L, Ruhrmann S, Petrovsky N, et al
    Neurocognitive functioning in parents of schizophrenia patients: Attentional and executive performance vary with genetic loading.
    Psychiatry Res. 2015 Nov 19. pii: S0165-1781(15)30699.
    PubMed     Text format     Abstract available


  543. RIGUCCI S, Santi G, Corigliano V, Imola A, et al
    White matter microstructure in ultra-high risk and first episode schizophrenia: A prospective study.
    Psychiatry Res. 2015 Nov 18. pii: S0925-4927(15)30158.
    PubMed     Text format     Abstract available


  544. FRYDECKA D, Beszlej JA, Goscimski P, Kiejna A, et al
    Profiling cognitive impairment in treatment-resistant schizophrenia patients.
    Psychiatry Res. 2015 Nov 18. pii: S0165-1781(15)30695.
    PubMed     Text format     Abstract available


  545. GRIGOROIU-SERBANESCU M, Diaconu CC, Heilmann-Heimbach S, Neagu AI, et al
    Association of age-of-onset groups with GWAS significant schizophrenia and bipolar disorder loci in Romanian bipolar I patients.
    Psychiatry Res. 2015 Nov 10. pii: S0165-1781(15)30052.
    PubMed     Text format     Abstract available


  546. NYKANEN S, Puska V, Tolonen JP, Salo H, et al
    Use of psychiatric medications in schizophrenia and other psychoses in a general population sample.
    Psychiatry Res. 2015 Nov 10. pii: S0165-1781(15)30654.
    PubMed     Text format     Abstract available


  547. HWANG SS, Ahn YM, Kim YS
    Neurocognitive functioning as an intermediary variable between psychopathology and insight in schizophrenia.
    Psychiatry Res. 2015 Nov 9. pii: S0165-1781(15)30618.
    PubMed     Text format     Abstract available


  548. PHALEN PL, Viswanadhan K, Lysaker PH, Warman DM, et al
    The relationship between cognitive insight and quality of life in schizophrenia spectrum disorders: Symptom severity as potential moderator.
    Psychiatry Res. 2015 Nov 6. pii: S0165-1781(15)30060.
    PubMed     Text format     Abstract available


  549. NELSON BD, Bjorkquist OA, Olsen EK, Herbener ES, et al
    Schizophrenia symptom and functional correlates of anterior cingulate cortex activation to emotion stimuli: An fMRI investigation.
    Psychiatry Res. 2015 Nov 6. pii: S0925-4927(15)30098.
    PubMed     Text format     Abstract available


  550. DEAN OM, Mancuso SG, Bush AI, Copolov D, et al
    Benefits of adjunctive N-acetylcysteine in a sub-group of clozapine-treated individuals diagnosed with schizophrenia.
    Psychiatry Res. 2015 Nov 2. pii: S0165-1781(15)30605.
    PubMed     Text format    


    October 2015
  551. ANDERSON VM, McIlwain ME, Kydd RR, Russell BR, et al
    Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders?
    Psychiatry Res. 2015 Oct 31. pii: S0165-1781(15)30604.
    PubMed     Text format     Abstract available


  552. VAN ERP TG, Preda A, Turner JA, Callahan S, et al
    Neuropsychological profile in adult schizophrenia measured with the CMINDS.
    Psychiatry Res. 2015 Oct 26. pii: S0165-1781(15)30569.
    PubMed     Text format     Abstract available


    September 2015
  553. VASKINN A, Hartberg CB, Sundet K, Westlye LT, et al
    To the editors: Reply to Anna R. Docherty.
    Psychiatry Res. 2015;233:497.
    PubMed     Text format    


    August 2015
  554. DOCKERY L, Jeffery D, Schauman O, Williams P, et al
    Stigma- and non-stigma-related treatment barriers to mental healthcare reported by service users and caregivers.
    Psychiatry Res. 2015;228:612-9.
    PubMed     Text format     Abstract available


  555. VAN HEUGTEN-VAN DER KLOET D, Giesbrecht T, van Wel J, Bosker WM, et al
    MDMA, cannabis, and cocaine produce acute dissociative symptoms.
    Psychiatry Res. 2015;228:907-12.
    PubMed     Text format     Abstract available


    July 2015
  556. KOELKEBECK K, Kohl W, Luettgenau J, Triantafillou S, et al
    Benefits of using culturally unfamiliar stimuli in ambiguous emotion identification: A cross-cultural study.
    Psychiatry Res. 2015;228:39-45.
    PubMed     Text format     Abstract available


  557. ROCHE MW, Fowler ML, Lenzenweger MF
    Deeper into schizotypy and motor performance: Investigating the nature of motor control in a non-psychiatric sample.
    Psychiatry Res. 2015;228:20-5.
    PubMed     Text format     Abstract available


    June 2015
  558. O'CONNOR K, Nelson B, Lin A, Wood SJ, et al
    Are UHR patients who present with hallucinations alone at lower risk of transition to psychosis?
    Psychiatry Res. 2015 Jun 29. pii: S0165-1781(15)00398.
    PubMed     Text format     Abstract available


    April 2015
  559. DENG Y, Goodrich-Hunsaker NJ, Cabaral M, Amaral DG, et al
    Disrupted fornix integrity in children with chromosome 22q11.2 deletion syndrome.
    Psychiatry Res. 2015;232:106-14.
    PubMed     Text format     Abstract available


  560. OTA M, Ogawa S, Kato K, Wakabayashi C, et al
    Methamphetamine-sensitized rats show augmented dopamine release to methylphenidate stimulation: a positron emission tomography using [18F]fallypride.
    Psychiatry Res. 2015;232:92-7.
    PubMed     Text format     Abstract available


    March 2015
  561. ZIK JB, Roberts DL
    The many faces of oxytocin: implications for psychiatry.
    Psychiatry Res. 2015;226:31-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: